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AIM OF THE WORK 
Within the recent decades, increasing attention has been paid on the discovery and 
exploitation of natural products from plants, bacteria, and fungi. Natural products are 
often secondary metabolites, which have biological activities and pharmacologically 
interesting properties, and may act as antibiotics, insecticides, herbicides, antifungals, 
cytostatics, anticholesteremics, antiparasitics, or antitumor drugs (Reichenbach and 
Hofle 1993). Thus, a great number of secondary metabolites are widely commercially 
available as e.g. medicines, but also as flavor and fragrance ingredients, food additives, 
and agrochemicals (Vijaya Sree et al. 2010).  
During the last 20 years, myxobacteria have been known to be one of the major sources 
of microbial secondary metabolites besides actinomycetes and fungi. Their ability to 
produce a variety of structurally unique compounds and metabolites with rare biological 
activities made them a promising source of novel pharmaceutically interesting 
compounds (Bode and Müller 2006; Wenzel and Müller 2007). More than 100 different 
basic compounds and approximately 500 structural variants have been isolated from 
these organisms (Reichenbach 2001; Gerth et al. 2003). About 7.500 different 
myxobacteria have been isolated, and numerous strains have been analyzed chemically
(Gerth et al. 2003; Bode and Müller 2006; Wenzel and Müller 2007). Of these, 
members of the genus Sorangium produce nearly 50 % of the metabolites isolated from 
myxobacteria (Gerth et al. 2003; Schneiker et al. 2007). Sorangium cellulosum Soce 56, 
a myxobacterium with the largest genome yet discovered in bacteria, has been known as 
a producer of many novel low molecular weight natural products and valuable 
secondary metabolites such as chivosazol, etnangien and myxochelin (Schneiker et al. 
2007; Wenzel and Müller 2007). In 2007, the genome of Sorangium cellulosum So ce56 
was completely sequenced. Genomic data mining revealed 17 loci involved in 
secondary metabolism, including carotenoid and terpenoid biosynthesis (Schneiker et 
al. 2007). This opens up new possibilities to exploit secondary metabolites from this 
strain.  
If a promising compound is found, it may be applied in a natural or chemically modified 
form (Reichenbach and Hofle 1993). The modification of natural products by changing 
their chemical structures, e.g. adding functional groups to enhance or alter biological 
properties, is very important to develop new compounds. For example, camptothecin – a 
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compound found in the stem wood of the Chinese ornamental tree Camptotheca 
acuminata can act as an interesting anticancer drug by inhibiting DNA topoisomerase I. 
However, its therapeutic activity is easily lost due to the intrinsic instabilities resulting 
from the rapid hydrolysis of the lactone ring in the body. Therefore, modification this 
compound to an analogue with adequately long biological life/activity in its active 
lactone form has been received a lot of attention from scientists (Srivastava et al. 2005). 
In chemical organic syntheses, regio- or stereo-selective oxidation is key reaction. 
However, these reactions are difficult to be achieved by chemical synthetic processes, in 
addition to cost and time inefficiency as well as hazardous impact (Curci et al. 2006; 
Bicas et al. 2009). In contrast, bio-catalysts, especially, cytochrome P450 mono-
oxygenases, are considered as an alternative approach for regioselective modifications 
because of their ability to introduce atomic oxygen into allylic positions, double bonds 
or even into non-activated C–H bonds, and have thus a great potential for application in 
the production of natural molecules (van Beilen et al. 2003; Urlacher et al. 2004, 
Bernhardt 2006, Cankar 2011).  
In the context of the So ce56 genome project, a cooperation between the Institute of 
Biochemistry and the Institute of Pharmaceutical Biotechnology at Saarland University 
was initiated to exploit the cytochromes P450 of this myxobacterial strain. During his 
PhD thesis, Dr. Yogan Khatri cloned and expressed all 21 P450s of So ce56 in E. coli 
and also characterized some of them, e.g CYP109D1 and CYP260A1 (Khatri PhD 
thesis 2009). Continuing a part of this project, my work is targeted at the charaterization 
of CYP264B1, one of 21 P450s of So ce56. Since the gene coding for CYP264B1 is 
located in a cluster with gene coding for a terpene cyclase gene, characterization of 
CYP264B1 and the neighbouring terpene cyclase to elucidate the biological function of 
this cluster in the terpene biosynthetic pathway of myxobacteria So ce56 is very 
interesting for both basic research and industrial application.  
By using modern molecular biology techniques and various chemical analysis methods, 
the presented work focuses on the characterization of two important enzymes, 
CYP264B1 and a terpene cyclase, of a gene cluster of S. cellulosum So ce56. The 
purposes of the work are: (i) understanding the characteristics of CYP264B1, including 
substrate specificity and catalytic functions, (ii) screening potential substrates of 
CYP264B1, (iii) characterizing the terpene cyclase to elucidate the role of the terpene 
biosynthesis gene cluster in the biosynthetic pathway of S. cellulosum So ce56. 
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1. INTRODUCTION 
1.1. Myxobacterium Sorangium cellulosum So ce56 
1.1.1. General information 
Myxobacteria are a large group of bacteria living predominantly in the soil. They do not 
have flagella and move on solid surfaces by gliding. Some physiological characteristics 
of So ce56 are shown in Figure 1.1. In comparison to other bacteria, genomes of 
myxobacteria are very large, about 9-10 million nucleotides. In 2007, the complete 
genome sequence of Sorangium cellulosum So ce56 was released, and it is the largest 
bacterial genome reported to date, with 13,033,799 base pairs. Genome analysis of So 
ce56 revealed a GC content of 71.38%, coding sequences of 86.45%, and 9,367 
predicted protein-coding sequences (Schneiker et al. 2007).  
Myxobacteria represent a very promising source for the discovery of novel classes of 
secondary metabolites. From these, the genus Sorangium is particularly valuable with 
approximately 50% of metabolites isolated from myxobacteria (Gerth et al. 2003; 
Schneiker et al. 2007). Genome sequencing has revealed that So ce56 possesses a high 
metabolic potential. This strain is known to produce natural products as chivosazole and 
myxochelin as well as the polyketide metabolite etnangien which is an inhibitor of 
bacterial and viral nucleic acid polymerases (Schneiker et al. 2007). 
The So ce56 genome encodes a large number of biotechnologically important enzymes, 
including proteases, nitrilases, lipases, amidases, cellulases, and hydantoinases. In 
addition, numbers of genes encoding members of the short-chain 
dehydrogenase/reductase, S8 family peptidases and subtilisin-like enzymes were also 
found in the genome of this strain, providing a great potential for industrial production 
of chiral alcohols and additives used in laundry detergents (Schneiker et al. 2007). 
Especially, the So ce56 genome contains 21 putative cytochromes P450 which are 
known as versatile biocatalysts (Bernhardt 2006; Schneiker et al. 2007).  
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Figure 1.1: Physiological characteristics of So ce56. (a) S. cellulosum colonies, (d) 
Fruiting bodies (Schneiker et al. 2007) 
1.1.2. A terpene biosynthesis gene cluster of So ce56 
The genome of the myxobacterium So ce56 has three locus_tags of terpene cyclases 
(sce1440, sce6369 and sce8552) which are potentially involved in the carotenoid and 
terpenoid biosynthesis (Schneiker et al. 2007). Locus sce1440 encodes a putative 
terpene cyclase composed of 771 amino acids located between locus sce1439 (encodes a 
major facilitator superfamily permease) and sce1441 (encodes a nucleotide-binding 
protein) with a distance of 528 and 21 bp, respectively. This putative terpene cyclase 
has substantial similarity to genes in other bacteria that are involved in the biosynthesis 
of geosmin, a sesquiterpene-derived natural product that gives soil its characteristic 
smell (Dickschat et al. 2005; Jiang et al. 2006; Schneiker et al. 2007). Locus sce6369 
encodes a predicted pentalenene synthase composed of 315 amino acids with major 
domains for terpene cyclases and located between two hypothetical proteins with a 
distance of 614 and 59 bp. Locus sce8552 is a putative terpene cyclase (gene name: 
geoA). It is located at 63 bp downstream of the gene coding for a cytochrome P450 - 
CYP264B1 (gene name: CypA8) and 81 bp upstream of a protein kinase (NCBI). The 
distance of 63 base pairs between CYP264B1 and GeoA implies that they are likely 
arranged in an operon and together involved in the biosynthesis of terpenoids in So ce56 
(Khatri 2011). CYP264B1 and the terpene cyclase GeoA are therefore regarded as a 
terpene biosynthesis gene cluster (TPSgc) of So ce56 (Figure 1.2). 
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Figure 1.2: Organization of genes coding for CYP264B1 and terpene cyclase GeoA 
in the TPSgc of the myxobacterium Sorangium cellulosum So ce56  
1.2. Cytochromes P450 
1.2.1. General aspects 
Cytochromes P450 belong to the superfamily of heme-containing monooxygenase 
enzymes (Ruckpaul et al. 1989; Bernhardt 2006). They are often abbreviated as CYP or 
P450. Their name is based on their character as hemoproteins (cytochrome), pigment 
(P) and the typical absorption band at 450 nm of their reduced carbon-monoxide bound 
form (Omura and Sato 1964). This unusual spectral property is induced by a cysteine 
thiolate group (Ichikawa 1967; Murakami 1967), forming the fifth ligand of the heme 
iron (Hannemann et al. 2006). The ability of reduced, CO-bound P450 to produce an 
absorption peak at 450 nm is used for the estimation of the P450 concentration (Omura 
and Sato 1964). The members of the P450 superfamily are classified according to the 
recommendation of a nomenclature committee (Nelson et al. 1996), based on amino 
acid identity, phylogenetic criteria and gene organization (Werck-Reichhart and 
Feyereisen 2000). They are designated as CYP, followed by an Arabic number for the 
gene family (with more than 40% amino acid identity), a capital letter indicating the 
subfamily (with more than 55% amino acid identity), and another numeral for the 
individual gene, e.g. CYP106A2, CYP264B1, CYP260A1.
Cytochromes P450 are found in all domains of life, from eukaryotes to prokaryotes and 
even virus (Lamb et al. 2009). Plants have the highest number of P450s, human has 57 
P450s, while Escherichia coli has none. In bacteria, P450s are involved in catabolism of 
compounds used as energy or carbon sources (Gunsalus et al. 1978; Schiffler et al. 
63 bp
             990bp                1239 bp 
CYP264B1
sce8551
Terpene cyclase 
sce8552
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2003), detoxification of xenobiotics (Taylor et al. 1999), metabolism of fatty acids and 
biosynthesis of antibiotics (Werck-Reichhart et al. 2000; Bernhardt 2006). In yeast and 
fungi, they are involved in the synthesis of membrane sterols and mycotoxins, 
detoxification of phytoalexins, and metabolism of lipid carbon sources (Kalb et al. 
1987; Werck-Reichhart et al. 2000). In insects, P450s are required for juvenile hormone 
synthesis (Helvig et al. 2004), catabolism of ecdysteroids and detoxification of foreign 
chemicals (Feyereisen 1999). In plants, P450s play an important role in the synthesis of 
cutin and lignin barriers and of defense substances, UV protectants, flower pigments, 
plant hormones, defensive compounds (Kahn et al. 2000, Schuler and Werck-Reichhart 
2003). In mammals, they take part in the production of signaling molecules, steroid 
hormones and retinoic acid (Hasler 1999), are involved in the biosynthesis of steroid 
hormones, vitamin D, fatty acids and drug metabolism (Guengerich et al. 2005).  
P450s catalyze more than 20 different reactions summarized by Dawson and coworkers 
(Sono et al. 1996) (Table. 1.1) and some more unusual reactions were mentioned by  
Guengerich and coworkers (Guengerich et al. 2001). The most common reaction 
catalyzed by P450s is a monooxygenase reaction in which one atom of oxygen is 
inserted into an organic substrate (RH) while the other oxygen atom is reduced to water 
(Mansuy et al. 1998):  
RH + O2 + NAD(P)H + H
+ → ROH + H2O + NAD(P)
+
Table 1.1:  Reactions catalyzed by cytochromes P450, according to (Sono et al. 
1996) 
Reactions 
Hydrocarbon hydroxylation Oxidative dehalogenation 
Alkene epoxidation Alcohol and aldehyde oxidations 
Alkyne oxygenation Dehydrogenation 
Arene epoxidation Dehydratations 
Aromatic hydroxylation Reductive dehalogenation 
N-Dealkylation N-Oxide reduction 
S- Dealkylation Epoxide reduction 
O- Dealkylation Reductive β-scission of alkyl peroxides 
N-Hydroxylation NO reduction 
N-Oxidation Isomerizations 
S-Oxidation Oxidative C-C bond cleavage 
Oxidative deamination  
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Due to their capability of performing various reactions on a variety of substrates, 
cytochromes P450 are considered as versatile biocatalysts and have great application 
potential (Bernhardt 2006; Urlacher and Eiben 2006; Urlacher and Girhard 2011). For 
example, a P450 monooxygenase has been used for the biotransformation of steroids to 
hydrocortisone with Curvularia sp at comercial scale (Petzoldt et al. http://www. 
schering.de); they were applied for the production of transgenic plants such as 
carnations and blue roses (Holton et al. 1993; Ogata et al. 2005) and for the production 
of vitamin D analogs (Sakaki et al. 1999). Nowadays, with the possibilities of genetic 
engineering techniques and various mutagenesis methods, the diversity of P450-
catalyzed reactions becomes more and more available and applicable to 
biotechnological use (Bernhardt 2006). 
1.2.2. Catalytic mechanism 
A common catalytic cycle of the cytochromes P450 was proposed in 1968 (Gunsalus et 
al. 1975; Griffin 1979) and then updated by Denisov et al. (Denisov et al. 2005). This 
cycle includes substrate binding, reduction of the ferric heme, binding of molecular 
oxygen, activation of oxygen, insertion of an iron-bound oxygen into the substrate, and 
product release (Figure 1.3).  
Figure 1.3: The catalytic cycle of cytochrome P450 (Denisov et al. 2005) 
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According to Gunsalus et al. (Gunsalus et al. 1975), Griffin (Griffin 1979) and Denisov 
et al. (Denisov et al. 2005), the catalytic cycle of the cytochromes P450 can be 
described as follows: (1) P450 in the substrate-free form: The ferric heme iron Fe (III) is 
in the low-spin state, and the sixth coordination position opposite the cysteinate is 
occupied by a water molecule as the distal ligand. (2) Substrate binding: Substrate binds 
to the enzyme active site, mostly by hydrophobic interaction in the vicinity of the heme 
and displaces the water molecule. This induces a low- to high-spin shift of the heme 
iron and an increase of the reduction potential of the enzyme heme, which favors the 
electron uptake. The five-coordinate iron atom is out of the porphyrin plane. (3) The 
first reduction: Fe3+ ion is reduced by an electron transferred from NAD(P)H via an 
electron transfer chain, results in a high-spin ferrous state Fe (II). (4) Oxygen binding: 
Molecular oxygen binds covalently to the distal axial coordination position of the heme 
iron, forming a superoxide complex Fe2+-OO then undergoes a slow conversion to a 
more stable complex Fe3+-OO-, resulting in “in plane” coordination which is the last 
relatively stable intermediate in this cycle. (5a) Second reduction: One-electron 
reduction of this complex by insertion of the second electron to a ferric peroxo state 
Fe3+-OO2-, which is easily protonated to form the hydroperoxoferric Fe3+-OOH- 
intermediate (5b). (6) Oxygene cleavage: After the formation of an unstable transient 
Fe-OOH2 from the Fe
3+-OOH- complex, a heterolytic scission of the O-O bond occurs, 
following the release of the water molecule and the generation of the ferryl-oxene (O = 
FeIV) activated oxygen intermediate. (7) Product formation and release: The active 
ferryl-oxene inserts an oxygen atom into the substrate forming a hydroxylated form of 
the substrate. The monooxygenated product can be released from the active site of the 
enzyme, which returns to its initial state. In addition, there are three abortive branch 
points, which can possibly occur under physiological conditions: (i) auto-oxidation of 
the oxy-ferrous enzyme (4) together with a release of a superoxide anion and return of 
the enzyme to its resting state (2), (ii) a peroxide shunt, where the coordinated peroxide 
or hydroperoxide anion (5a, b) dissociates from the iron forming hydrogen peroxide, 
thus completing the unproductive (in terms of substrate turnover) two electron reduction 
of oxygen, and (iii) an oxidase shunt at the stage of the ferryl-oxo intermediate (6) 
where oxygen is reduced to water instead of being introduced into the substrate 
(Denisov et al. 2005).  
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1.2.3. Electron transport systems  
Cytochromes P450 are external monooxygenases, since they utilize electrons from an 
external donor to activate molecular oxygen for substrate conversion. For almost all 
P450s, the electrons cannot be transferred directly from NAD(P)H to the P450 but are 
mediated via an electron transfer chain (ETC). The components participating in an ETC 
are called redox partners. As the cytochrome P450 enzyme family is widespread in 
nature, their catalytic functions and the composition of their electron transfer chains are 
variable. Based on the types of redox proteins participating in electron transfer, 
Hannemann et al. (Hannemann et al. 2007) classified known P450s into 10 classes as 
shown in Figure 1.4 and summarized as follows: 
Class I P450s includes most bacterial cytochromes as well as the mitochondrial P450s 
from eukaryotes. In this class, the electrons (reduction equivalents) are transferred from 
NAD(P)H to a FAD-containing reductase (FdR). Then, they are transferred to a 
ferredoxin (Fdx) which in turn reduces the P450s. In class II P450s, the ETC is 
composed of the cytochrome P450 and the NADPH cytochrome P450 reductase (CPR) 
located in the endoplasmic reticulum (ER). The CPR contains the prosthetic groups 
FAD and FMN which transfer electrons from NADPH to the P450. Class III P450s has 
been typically found in bacteria. The system consists of FdR, Flavodoxin (Fldx) 
containing FMN and the novel cytochrome P450cin (discovered from Citrobacter 
braakii). The Class IV P450s system includes Fdx and its corresponding partner, 2-
oxoacid ferredoxin oxidoreductase (OFOR). Such a system has been found in 
Sulfolobus solfataricus. Class V P450s system contains putative NAD(P)H-dependent 
reductase (FdR) and a cytochrome P450-ferredoxin-fusion protein (Fdx-P450). The 
class VI P450s system is composed of a putative NAD(P)H-dependent flavoprotein 
reductase (FdR) and a flavodoxin-P450-fusion protein (Fldx-P450). Class VII P450s 
constitutes a fusion of the phthalate-family oxygenase with P450 (PFOR-P450). Class 
VIII P450s contains P450s fused to their eukaryotic-like diflavin reductase partner 
(CPR-P450). Class IX P450s comprises nitric oxide reductase (P450nor) using NADH 
as an electron donor. P450nor catalyzes dependent of NADH and independent of other 
electron transfer proteins. Class X P450s consists of independent redox partner P450s. 
This P450 group includes allene oxide synthase, fatty acid hydroperoxide lyase, divinyl 
ether synthase, prostacyclin synthase and thromboxane synthase (Hannemann et al. 
2007). 
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Figure 1.4: Schematic organization of different cytochrome P450 systems. (A) 
Class I, bacterial system; (B) class I, mitochondrial system; (C) class II, microsomal 
system; (D) class III, bacterial system; (E) class IV, bacterial thermophilic system; (F) 
class V, bacterial [Fdx]–[P450] fusion system; (G) class VI, bacterial [Fldx]–[P450] 
fusion system; (H) class VII, bacterial [PFOR]–[P450] fusion system; (I) class VIII, 
bacterial [CPR]–[P450] fusion system; (J) class IX, soluble eukaryotic P450nor; (K) 
class X, independent eukaryotic system (Hannemann et al. 2007) 
   
1.2.4. Structural features 
Despite of sequence identity across the gene super family being less than 20%, 
cytochromes P450 share a common overall fold and topology (Hasemann 1995). In 
general, there are approximately thirteen -helices and four -strands in P450 proteins 
(Peterson and Graham 1998). The conserved P450 structural core is formed by a four-
helix bundle around the heme (three parallel helices D, L, I and one antiparallel helix E) 
(Presnell et al. 1989) (Figure 1.5). The prosthetic heme group (a tetrapyrrole heme b) is 
located between the distal I helix and proximal L helix and bound to the adjacent 
cystein heme- ligand loop containing the P450 signature amino acid sequence 
FxxGx(H/R)xCxG. The absolutely conserved cysteine is the proximal or “fifth” ligand 
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to the heme iron. Typically, the proximal cystein forms two hydrogen bounds with 
neighboring backbone amides (Denisov et al. 2005).  The long I helix forms a wall of 
the heme pocket and contains the signature amino acid sequence (A/G)-Gx(E/D)T 
which is centered at a kink in the middle of the helix. The I-helix also contains a highly 
conserved threonine that is positioned in the active site and is believed to be involved in 
catalysis (Imai et al. 1989; Martinis et al. 1989; Kimata et al. 1995). The 6 substrate 
recognition sites (SRS) proposed by Gotoh et al. (Gotoh et al. 1992) and are based on 
sequence alignments between members of the CYP2 family and P450cam. These 
protein regions are considered to be flexible and move upon substrate binding in an 
induced-fit mechanism to favor substrate binding and subsequently the catalytic 
reaction (Pylypenko and Schlichting 2004; Denisov et al. 2005). An example of 
cytochrome P450 structure is shown in Figure 1.5. 
Figure 1.5: A ribbon diagram of the human cytochrome P450 2D6 structure. α-
helices are shown in blue, β-strands in mauve. The heme group is shown in ball and 
stick, and its structure is described in the callout 
 (http://www.esrf.eu/Industry/UsersAndScience/Publications/Highlights/2006/SB/SB09)  
1.2.5. Interactions of cytochromes P450 with their ligands  
Since the heme prosthetic group serves as the chromophore of a cytochrome P450, 
interactions between ligands and P450s occurring at the heme lead to a change in the 
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UV/vis spectra. In general, three types of binding spectra have been identified: type I, 
type II and type III (or reverse type I) (Schenkman et al. 1981). Type I shows a Soret 
absorption peak at 390 nm and a trough at 420 nm (Gibson and Skett 1994). This type is 
often observed in substrate bound forms. Type II is characterized by a decrease in 
absorption at around 390-405 nm and an increase at about 425-435 nm. Type III binding 
spectrum displays an increase of the 420 nm signal and a reduction of absorbance at 390 
nm (Schenkman et al. 1981). The type II and III spectra are mostly observed upon the 
binding of an inhibitor instead of a substrate. However, some type II ligands can also act 
as substrates (Gigon et al. 1969; Kunze et al. 2006; Pearson et al. 2006). Type I and II 
are shown in Figure 1.6.
Figure 1.6: The UV-difference spectra of cytochrome P450 in different form. The 
type I is shown in black line, the type II is shown in red line 
(http://www.tcm.phy.cam.ac.uk/~mds21/thesis/node50.html) 
P450s in the resting state exist in an equilibrium between low-spin (one unpaired 
electron, S = 1/2) or high-spin iron (five unpaired electrons, S = 5/2) (Denisov et al.
2007). The low-spin enzyme is hexacoordinated with water as the sixth axial ligand, and 
has an absorption maximum at around 418 nm (416-420 nm). The high-spin species is 
pentacoordinate with dissociated water and the iron is located slightly under the plane of 
the heme with a shortened iron–sulfur bond length (Conner et al. 2011). In this high 
spin state, the absorption maximum shifts to 390 nm (385-394 nm). The interaction of 
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ligands with the active site of CYPs leads to a spin-shift in the heme iron structure 
concomitant with a decrease in the reduction potential from -300 mV to a positive value 
(100 mV) (Guengerich et al. 1975; Williams-Smith and Cammack 1977; Guengerich 
1983; Daff et al. 1997; Fantuzzi et al. 2004, Denisov et al. 2005). These ligand-induced 
changes can be explained as follows: In the resting state, the heme iron of P450s exists 
in the ferric Fe3+ form and the reduction potential of Fe3+/Fe2+ is in the range of -400 to 
-170 mV (Guengerich 1975). In the absence of a ligand, a water molecule coordinates 
with the sixth distal axial coordination position of the heme and stabilizes the low spin 
state of the ferric iron. Upond ligand binding the water molecule is displaced by the 
ligand leading to a shift of the hexa-coordinated low spin state to the penta-coordinated 
high spin state. Consequently, the heme iron is transformed into a thermodynamically 
unstable state (Fe2+ form), and the redox potential is directed to a more positive value. 
The stronger the ability of the substrate to disturb the water interaction with the ferric 
heme, the more pronounced is the resulting positive shift of the redox potential. The 
equilibrium of the low spin and the high spin state is also influenced by ambient 
parameters such as temperature, pH as well as the presence of co-solvents (Denisov et 
al. 2005). 
1.3. Terpene cyclases and terpenoid biosynthesis 
1.3.1. Terpenoids 
The terpenoids belong to the largest and most diverse class of natural products. More 
than 30000 individual terpenoids, the majority of which is isolated from plants, have 
been identified (Buckingham 1998). The building blocks of terpenoids are isoprenes 
(5C). Based on the number of the isoprene units, terpenes can be divided into 
hemiterpenes (C5), monoterpenes (C10), sesquiterpenes (C15), diterpenes (C20), 
triterpenes (C30), tetraterpenes (C40) and polyterpenes (C5)n where n varies from 9 to 
30000. The best-known monoterpenes are camphor, limonene, menthol. Other 
important terpenoid examples are sesquiterpenes, e.g. patchoulol, abscisic acid, 
pentalenolactone or diterpenes, e.g. taxol, casbene and gibberellin (McGarvey and 
Croteau 1995, Davis and Croteau 2000). Terpenoids often have multicyclic structures. 
Each differs from one another not only in functional groups but also in their basic 
carbon skeletons (Yermakov et al. 2010). In plants, they are involved in primary 
metabolism, as e.g. growth hormones (gibberellins, abscisic acid), photosynthetic 
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pigments (phytol, carotenoids, the side chain of chlorophyll), as electron carriers 
(ubiquinone, plastoquinone), mediators of polysaccharide assembly (polyprenyl 
phosphates) and structural components of membranes (phytosterols) (McGarvey and 
Croteau 1995). Besides physiological, metabolic and structural functions, terpenoid 
compounds are also involved in communication and defense, for example as attractants 
for pollinators and seed dispersers, competitive phytoxins, antibiotics and herbivore 
repellents and toxins (Harborne 1991; McGarvey and Croteau 1995). Due to their 
biological activities and physico-chemical properties, many terpenoids are important 
renewable resources providing a range of commercially useful products, including 
solvents, flavorings and fragrances, adhesives, coatings and synthetic intermediates 
(Harborne 1991; McGarvey and Croteau 1995; Dawson 1994). They also provide 
industrially useful polymers (rubber, chicle) and a number of pharmaceuticals 
(limonene, artemisinin, taxol) (Crowell and Gould 1994; Van Geldre et al. 1997) and 
agrochemicals (pyrethrins, azadirachtin) (Harborne 1991). Some of these terpenoids are 
available in relatively large amounts as essential oils, resins, and waxes, but others 
which are naturally produced only in trace amounts are in short supply.  
1.3.2. Terpenoid biosynthesis pathways 
The biosynthesis of terpenoids can be divided into four major processes. The first stage 
is the biosynthesis of the active isoprene unit, isopentenyl pyrophosphate (IPP) and its 
following isomerization to dimethylallyl diphosphate (DMAPP) by IPP isomerase. 
Sequentially, this precursor can be converted by various prenyltransferases to higher 
order terpenoid building blocks, geranyl pyrophosphate (GPP; C10), farnesyl 
pyrophosphate (FPP; C15), and geranylgeranyl pyrophosphate (GGPP; C20). The next 
stage includes cyclization to create the basic parent skeletons of the various terpenoid 
families or self-condensation reactions to form the C30 and C40 precursors of sterols and 
carotenoids, respectively). Finally, oxidation, reduction, isomerization, conjugation, or 
other secondary transformations elaborate the unique and manifold character of the 
terpenoids (McGarvey and Croteau 1995).  
The building blocks for the biosynthesis of terpenes, IPP and DMAPP, can be 
synthesized via two pathways: the mevalonate-dependent pathway (referred to as the 
MVA pathway) and the mevalonate-independent pathway (referred to as the MEP 
pathway or DXP pathway) (Rohmer 1993; Schwender 1996; Lichtenthaler 1997; Adam 
1998; Rohmer 1999; Tholl 2006). These two pathways are illustrated in Figure 1.7.  
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Figure 1.7: Isoprenoid biosynthetic pathway. Isoprenoids are synthesized via two 
biosynthetic pathways: MVA pathway and MEP pathway. CoA is coenzyme A; HMG is 
3-hydroxy-3-methylglutaryl; MVA is mevalonic acid; PMVA is mevalonate-5-
phosphate; DPMVA is mevalonate-5-pyrophosphate; DXP is 1-Deoxy-D-xylulose 5-
phosphate; MEP is 2-C-methylerythritol 4-phosphate; CDP-ME is 4-diphosphocytidyl-
2-C-methylerythritol, MecPP is 2-C-methyl-D-erythritol 2,4-cyclopyrophosphate; 
HMBPP is (E)-4-hydroxy-3-methylbut-2-enyldiphosphate (Harada et al. 2009) 
In general, eukaryotes use the MVA pathway exclusively to convert acetyl-CoA to IPP 
and DMAPP precursors, except plants using both the MVA and MEP pathways for 
isoprenoid synthesis (Boucher and Doolittle 2000; Rohdich et al. 2002). By contrast, in 
prokaryotes, isoprenoids are synthesized primarily via the MEP pathway (Boucher and 
Doolittle, 2000). For example, most Streptomyces strains have only the MEP pathway, 
but some of them use MVA pathway for the formation of isopentenyl diphosphate 
(Dairi 2005). For myxobacteria, the mevalonate pathway has been shown to be active in 
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Myxococcus xanthus (Horbach et al. 1993) and Stigmatella aurantiaca (Bode et al.
2003). However, it cannot be excluded that myxobacteria have both MVA and MEP 
routes (Bode et al. 2003). In E. coli, IPP and DMAPP are essential for the prenylation 
of tRNAs and the synthesis of FPP, which is used for quinone and cell wall biosynthesis 
(Connolly and Winkler 1989; Apfel et al. 1999). Nevertheless, E. coli does not naturally 
produce appreciable quantities of GPP or GGPP, the precursors for mono- and 
diterpenes, respectively (Reiling et al. 2004).   
Due to their important role in the isoprenoid biosynthesis, both MVA and MEP 
pathways are targets for metabolic engineering of terpenoid biosynthesis. In fact, many 
useful isoprenoids are present in a small quantity from their natural sources, and the 
chemical synthesis of these structurally complex compounds is often difficult and 
expensive. However, by introducing heterologous biosynthetic pathways into microbial 
host organisms, commonly into E. coli and S. cerevisiae, which are easy to manipulate, 
numbers of important terpenoid compounds have been produced at higher level 
(Takahashi et al. 2007; Muntendam et al. 2009; Misawa 2011). Succesful metabolic 
engineering examples are the attempt in production of amorphadiene - precursor to 
antimalarial artemisinin in E. coli (Martin 2003) and  the production of  paclitaxel - a 
clinically important natural product in S. cerevisiae (Engels et al. 2008). Undoubtedly, 
understanding the isoprenoid pathway at molecular level is a key for a successful 
application of metabolic engineering – a new approach in exploiting natural terpenoid 
products from either plants or microorganism. 
1.3.3. Terpene cyclases 
As mentioned above, most terpenoids are cyclic and derived from linear prenyl 
pyrophosphate precursors (GPP, FPP, GGPP) (McGarvey and Croteau 1995). The 
primary enzymes responsible for the cyclizations of these isoprenoid precursors are 
terpene cyclases (or terpene synthases) (Tholl 2006). Monoterpene cyclase catalyzes the 
cyclization of GPP to monoterpenes, sesquiterpene cyclase creates sesquiterpenes from 
FPP and diterpene cyclases generate diterpenes from GGPP (Davis and Croteau 2000). 
Terpene cyclases are divided into two major classes based on their types of cyclization 
(Bohlmann et al. 1998). The cyclization reaction of the class I is initiated by the 
ionization of polyprenyl diphosphates to an allylic carbocation, followed by cyclization 
and deprotonation to the olefin. In another way, the cyclization reaction of the class II is 
initiated by protonation at the terminal-double bond of polyprenyl diphosphate 
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substrates (Dairi 2005). The enormous structural variety of terpenoid compouds is 
mostly due to the evolution of a large terpene synthase superfamily (Tholl 2006). Until 
now, dozens of terpene cyclase genes from eukaryotes, but only a limited amount from 
prokaryotes, have been reported (Dairi 2005; Ikeda 2007). Thus, this is a promising new 
field for future research. 
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Figure 1.8: Outline of the formation of plant terpenes (Tholl 2006) 
1.3.3.1. Catalytic mechanism 
Terpene cyclases catalyze the cyclization of isoprenyl pyrophosphate precursors by a 
complex rearrangement reaction (Christianson 2006). The initiation step is a carbo-
cationic reactions, where  enzymes typically ionize the allylic pyrophosphate ester 
linkage of their substrate. Catalysis of this reaction is dependent on divalent metal ion 
co-factors, usually Mg2+, which were hypothesized to bind to and assist ionization of the 
pyrophosphate (Christianson 2006; Zhou and Peters 2009). Typical mechanisms are the 
reactions of the monoterpene cyclases (Figure1.9). These reactions start with the 
divalent metal ion-dependent ionization of the substrate GPP in the active site. The 
cationic intermediates then can undergo a series of cyclizations, hydride shifts or 
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rearrangements until the reaction is terminated by deprotonation or water capture 
(Christianson 2006; Degenhardt et al. 2009). This reaction mechanism was elucidated 
by Croteau and coworkers (Croteau 1987; Wise and Croteau 1998). However, 
monoterpene cyclases have an unusual feature, many of these enzymes produce multiple 
products. For example, besides the principal cyclic product limonene, limonene 
synthase generates smaller amounts of myrcene and α- and β-pinene (Colby et al. 1993; 
Günnewich 2007). The cyclization catalyzed by sesquiterpene and diterpene cyclases is 
performed in a similar manner to the one used by monoterpene cyclases, although in 
most cases, a preliminary isomerization step is not required because of the greater 
flexibility of the longer C15 or C20 chain (McGarvey and Croteau 1995; Degenhardt et 
al. 2009). After the initial cyclization, a series of reactions is carried out including 
secondary cyclization, deprotonation to a neutral intermediate, hydride shifts, methyl 
shifts and Wagner–Meerwein rearrangements (Degenhardt et al. 2009).  
Figure 1.9: The mechanisms of cyclic reaction of all monoterpene synthases start 
with the ionization of the geranyl diphosphate substrate. The resulting carbocation can 
undergo a range of cyclizations, hydride shifts and rearrangements before reaction is 
terminated by deprotonation or water capture. The formation of cyclic monoterpenes 
requires the preliminary isomerization of the geranyl cation to a linalyl intermediate 
capable of cyclization. The production of the initial cyclic species, the α-terpinyl cation, 
1. Introduction 19
opens the door to secondary cyclizations. The route to the central α-terpinyl 
intermediate is highlighted in grey and the reaction pathways to the major products of 
all cloned monoterpene synthases are shown. The formation of the acyclic 
monoterpenes linalool, myrcene and (E)-β-ocimene might proceed either via the geranyl 
cation or via the linalyl cation. The numbering of carbon atoms of intermediates and 
products refers to that for GPP (Degenhardt et al. 2009) 
1.3.3.2. Structure features 
Plant terpene synthases have strongly conserved amino acid sequences, as well as 
similar intron-exon organization and exon sizes, suggesting a common evolutionary 
origin (Trapp and Croteau 2001; Komatsu et al. 2008). In contrast, microbial terpene 
synthases in general show no overall sequence similarity either to one another, except 
for ones synthesizing the same product (Hohn 1999; Cane and Watt 2003). Of the 
known microbial terpene cyclases, sesquiterpene cyclases have been the most 
extensively studied family because x-ray crystal structures of several sesquiterpene 
cyclase enzymes have been solved (Lesburg et al. 1997; Starks 1997; Caruthers 2000; 
Rynkiewicz 2001).  
An important domain found in both plant and microbial terpene synthase family 
members is an aspartate-rich region, DDxxD (Figure 1.10) (Zhou et al. 2009; 
Degenhardt et al. 2009). It has been proven that this region is responsible for the 
binding of divalent metal ions that later react with the diphosphate moiety of the 
substrate (Lesburg et al. 1997; 1998; Starks et al. 1997). A highly conserved RxR motif 
located at about 35 amino acids upstream of the DDxxD has also been observed in 
terpene cyclases. This motif is involved in the complexation of the diphosphate function 
after ionization of the substrate to protect the carbo-cationic intermediates from a 
nucleophilic attack (Starks et al. 1997; Degenhardt et al. 2009). Another motif, 
NSE/DTE or (N/D)DXX(S/T)XXXE (metal binding residues in boldface), has been 
discovered by X-ray analysis of terpene cyclases (Rynkiewicz et al. 2001). It is believed 
to play a role as an additional metal cofactor-binding motif located on the opposite site 
of the active site entry. While the DDxxD motif is highly conserved throughout almost 
all plant terpene synthases, the NSE/DTE motif is likely less well conserved (Figure 
1.10) (Christianson 2006; Zhou et al. 2009; Degenhardt et al. 2009). It has been 
suggested that a water molecule could substitute for the hydroxyl side chain of the 
central serine/threonine in terpene synthases when a glycine is located at the position of 
the NSE/DTE motif. Additionally, an arginine-rich motif has been found at about 60 
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residues from the N-terminus of many monoterpene synthases. It has a pattern like a 
tandem arginine (RR) which might participate in the isomerization of GPP to a 
cyclizable intermediate, such as the linalyl cation. This motif can be absent in 
monoterpene synthases producing only acyclic compounds (Williams et al. 1998; 
Degenhardt et al. 2009).  
Figure 1.10: Alignment of the terpene synthases divalent metal binding motifs 
(DDxxD and NSE/DTE) for selected diterpene synthases (Zhou et al. 2009) 
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2. MATERIALS AND METHODS 
2.1. Materials 
All chemicals and reagents used in this work were analytic-grade. Valencene, α-/β-
ionone, (+)-nootkatone, α-humulene, (-)-α-copaen, clovene, (-)-isolongifolene-9-one, (+)-
α-longipinene, GPP, FPP, GGPP were purchased from Sigma-Aldrich, Germany. 
Restriction enzymes were purchased from New England Biolabs, Germany.
2.1.1. Bacterial strains 
Table 2.1: E. coli strains used in this work 
Strain Genotype Company 
BL21(DE3)  E. coli B F- dcm ompT hsd S (rB
-
mB
-
) Novagen 
C43(DE3) F– ompT gal dcm hsdSB(rB
-
 mB
-
)(DE3) (Miroux & 
Walker, 1996) 
TOP10F’ F’{lacIq,Tn10(TetR)}mcrA_(mrrhsdRMS-
mcrBC)80lacZ_M15_lacX74recA1araD1
39_(ara-leu)7697 galU galK rpsL (StrR) 
endA1 nupG 
Invitrogen 
2.1.2. Genomic DNA 
The genomic DNA of So ce56 was kindly provided by Dr Olena Perlova from Prof. Dr. 
Rolf Müller’s group, Institute for Pharmaceutical Biotechnology, Saarland University. 
The genomic DNA was isolated using the Puregene® Genomic DNA Purification Kit 
(Gentra, Minneapolis, USA) according to the manufacturer's instructions as described 
(Perlova et al. 2006). 
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2.1.3. Vectors  
Vector pET17b (the structure is illustrated in Appendix) was purchased from 
Invitrogen. Plasmid pGro12 containing the molecular chaperone groES-groEL was 
constructed by Nishihara (Nishihara et al. 1998). Vector pETC4 (Appendix) containing 
the CYP264B1 encoding gene was constructed previously by Dr. Yogan Khatri (Khatri 
PhD thesis 2009). Tricistronic vector pETMR5 (Appendix) containing CYP264A1, 
AdR and Adx encoding genes was kindly provided by Michael Ringle. The mevalonate 
vectors pAC-Mev (Figure 2.1) and pAC-Mv were kindly provided by Prof Norihiko 
Misawa, Research Institute for Bioresources and Biotechnology, Ishikawa Prefectural 
University, Japan. The plasmid pAC-Mev contains a cluster composed of five genes of 
the mevalonate pathway (encoding 3-hydroxy-3-methylglutaryl CoA (HMGCoA) 
synthase, HMG-CoA reductase, MVA kinase, phospho-mevalonate (PMVA) kinase, 
and diphosphomevalonate (DPMVA) decarboxylase) as well as the IPP isomerase gene 
from Streptomyces sp. strain CL190 (Harada et al. 2009). The plasmid pAC-Mv is 
derived from pAC-Mev by removing the genes encoding HMG-CoA reductase and 
HMG-CoA synthase and adding of a DNA fragment containing a multiple cloning site 
between HindIII and EcoRV (Yu et al. 2011) 
Figure 2.1: Mevalonate vector pAC-Mev (Harada et al. 2009) 
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2.1.4. Primers 
Oligonucleotides were synthesized by Eurofins MWG Synthesis Company (Ebersberg, 
Germany). The primers used in this work are listed in Table 2.1 (the rbs is underlined, 
restriction sites are italic, histidine-tag coding sequence is shown in bold) 
Table 2.1: List of primers 
Name Oligonucleotide sequences 
NdeI_GeoA_ For ccaatcatatgtcatctgatcgaactagcg 
HindIII_ His_GeoA_ Rev ccaataagctttcagtgatggtgatggtgatgtccagcgcgcacgatca
EcoRI_ rbs_ GeoA_For ccaatgaattcaaggagatataccatgtcatctgatcgaactagcgttg 
NotI _ GeoA _Rev ccaatgcggccgctcagtgatggtgatggtgatg 
AscI-rbs- C4 -For   ccaatggcgcgccaaggagatatacatatgactcg 
SpeI_C4_ Rev ccaatactagttcagtgatggtgatggtgatg 
2.1.5. Proteins 
Bovine AdR and Adx4-108 were kindly provided by Wolfgang Reinle. AdR was 
purified according to a procedure published by Sagara et al. (Sagara et al. 1993). Adx4-
108 was purified following a protocol developed in our group (Uhlmann et al. 1994). 
Ferredoxin and ferredoxin reductase from So ce56 were kindly provided by Dr. Kerstin 
Maria Ewen and purified as previously described (Ewen et al. 2009). 
2.1.6. Culture media 
Luria-Bertani (LB, Beckton Dickinson), Terrific broth (TB, Beckton Dickinson), 
Nutrient agar (NA, Sifin) media were used (Sambrook and Russell 2001). Ampicillin 
(Amp, Roth) of 100 µg/ml, kanamycin (Kan, Sigma) of 50 µg/ml, chloramphenicol 
(Cm, Sigma) of 30 µg/ml, isopropyl-beta-D-thiogalactopyranoside (IPTG, Sigma) of 1 
mM, and arabinose (Ara, Sigma) of 4 mg/ml, delta-aminolevulinic acid (δ-Ala, Fluka) 
of 0.5 mM final concentration were used in this study. 
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2.2. Methods 
Common procedures, including preparation of E. coli competent cells, plamid 
preparation, restriction digestions, plasmid transformations and other standard 
molecular biological techniques were carried out as previously described in Sambrook 
and Russell (Sambrook and Russell 2001). Polymerase chain reaction (PCR) was 
performed using phusion DNA polymerase (Finnzymes). Sodium dodecylsulphate 
polyacrylamid gelelectrophoresis (SDS-PAGE) was carried out according to Laemmli 
(Laemmli 1970). Protein was quantified using Bicinchoninic acid (BC) assay protein 
quantitation kit (Uptima Interchim, Montluçon, France). Material preparation for this 
part is illustrated in Appendix. 
2.2.1. Plasmid construction 
2.2.1.1. Construction of pETG for terpene cyclase GeoA expression 
The gene encoding the ORF of terpene cyclase (GeoA) was amplified from the genomic 
DNA of the myxobacterium So ce56 with forward primer NdeI_GeoA_For and reverse 
primer HindIII_ His_GeoA_Rev using PCR with the temperature program as follows: 
denaturation at 98°C for 2 min, followed by 29 cycles of 98°C for 30 seconds, 50°C for 
10 seconds, 72°C for 45 seconds and the final elongation at for 72°C 10 min. The target 
PCR fragment was then separated by agarose gel electrophoresis and afterwards 
purified using NucleoSpin (Macherey-Nagel) according to the manufacturer’s 
instructions. After digestion with NdeI and HindIII (NEB), the PCR fragment was 
ligated into pET17b using Fast-LinkTM DNA Ligation Kit (Invitrogen) according to the 
manufacturer’s instructions, in a PCR machine with the following thermal program: 
16°C for 15 min, 20°C for 15 min, 70°C for 15 min.  The sequence of the terpene 
cyclase gene was confirmed by automatic DNA sequencing at MWG Biotech. The 
obtained vector was named pETG. 
2.2.1.2. Construction of pETC4AA for in vivo conversion 
A DNA fragment containing adrenodoxin reductase (AdR) and truncated adrenodoxin 
(Adx) encoding genes with a Shine-Dalgarno site upstream of each gene was cut from 
the vector pETMR5 (Appendix) (a kind gift from Michael Ringle) by HindIII and 
EcoRI (NEB). This fragment was then inserted into vector pETC4 using the same 
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restriction sites, resulting in the tricistronic vector pETC4AA containing CYP264B1, 
AdR and Adx encoding genes. 
2.2.1.3. Construction of pETC4AAG for terpene production 
The gene encoding GeoA was amplified from vector pETG by PCR with thermal cycles 
as described in the section 2.2.1.1, using forward primer EcoRI_ rbs_GeoA_For and 
reverse primer NotI _GeoA _Rev. The EcoRI_rbs_GeoA_For primer introduced an 
EcoRI site and a Shine-Dalgarno site upstream of the ORF of the GeoA gene. The target 
PCR fragment was then digested by EcoRI and NotI and inserted into vector pETC4AA 
using the same restriction sites, resulting in the tetracistronic vector pETC4AAG 
(Figure 2.2). 
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Figure 2.2: Vector pETC4AAG. Genes coding CYP264B1, AdR, Adx, GeoA are 
represented in red, yellow, brown and green color, respectively 
2.2.1.4. Construction of pETGAA for terpene production 
A DNA fragment containing adrenodoxin reductase (AdR) and adrenodoxin (Adx) 
encoding genes was cut from vector pETMRTr5 by HindIII and EcoRI . This fragment 
was then inserted into vector pETG using the same restriction sites, resulting in the 
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tricistronic vector pETGAA containing terpene cyclase GeoA, AdR and Adx encoding 
genes. 
2.2.1.5. Construction of pAC-MvC4 for terpene production 
The gene encoding CYP264B1 was amplified from vector pETC4 by PCR reaction with 
thermal cycles as described in section 2.2.1.1, using forward primer AscI_rbs_C4_For 
and reverse primer SpeI_C4_Rev. The target PCR fragment was digested and inserted 
into vector pAC-Mv between AscI and SpeI. The vector obtained was designated pAC-
MvC4. 
2.2.2. Heterologous gene expression of CYP264B1 and GeoA 
E. coli strain BL21(DE3) was used for the expression of CYP264B1 and the terpene 
cyclase GeoA. Cells were co-transformed with the plasmid pET17b harboring 
cyp264B1 (or GeoA) and the plasmid pGro12 carrying genes encoding the chaperones 
GroES and GroEL. Transformants were plated on nutrient agar (NA) plates containing 
Amp (100 µg/ml) and Kan (50 µg/ml) and incubated overnight at 37°C. A single colony 
was picked and inoculated in 10 ml of Luria-Bertani (LB) containing Amp and Kan at 
37°C overnight under constant shaking. Overnight cultures were used to inoculate (1% 
v/v) 300 ml of terrific broth (TB) containing Amp and Kan in a 2-L baffled flask. The 
cultures were grown at 37°C under constant shaking until the optical density measured 
at 600 nm (OD600) reached 0.6-1.0. Cultures were then induced by addition of 1 mM of 
-D-1 thiogalactopyranoside (IPTG) and 4 mg/ml arabinose and grown at 27°C for 
another 48 h under constant shaking. For CYP264B1 expression, 0.5 mM of delta-
aminolevulinic acid (δ-Ala) was added at induction time to support the heme synthesis. 
2.2.3. Purification of His6-CYP264B1 and His6-GeoA 
Bacteria were harvested by centrifugation at 4000 g for 10min at 4°C and then 
resuspended in 10 mM potassium phosphate buffer, pH 7.4 containing 0.1 mM PMSF, 
300 mM NaCl and 10% glycerol. Cells were disrupted by sonication (USD 30, WV) for 
15 min on ice (Amplitude 25 m, Puls 30 s, Ratio 1) and then centrifuged at 30.000 rpm 
(Rotor P45, centifugator himac CP75β, Hitachi) for 30 minutes to remove cell debris. 
The supernatant was loaded onto an IMAC (immobilized metal ion affinity 
chromatography) column (TALONTM, Clontech). The purification was performed 
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according to the manufacturer’s instructions. Fractions containing His6-tagged protein 
were then collected and concentrated using centrifugal filter (Utracel 30k, 
AmiconUltra, Leatherland). For CYP264B1, these fractions were recognized by its red 
colour. For GeoA, these fractions were recognized by using Bicinchoninic acid (BC) 
assay protein quantitation kit (Uptima Interchim, Montluçon, France) according to the 
manufacturer’s instructions. The concentrated sample was applied to a Superdex 75 (GE 
Healthcare) column and the size exclusion chromatography was carried out at a constant 
flow rate of 0.1 ml min−1 with 10 mM potassium phosphate buffer, pH 7.4. Protein 
fractions of sufficient purity were pooled, concentrated and stored at -80°C. The purity 
and molecular mass of the proteins were estimated by SDS-PAGE (Laemmli 1970). The 
concentration of GeoA was measured with the BC assay as mentioned. The 
concentration of CYP264B1 was measured according to the CO-reduced difference 
spectra method (Omura and Sato 1964) as described below (section 2.2.4). 
2.2.4. Determination of P450s concentration 
The concentration of P450 was calculated using the CO-reduced difference spectra 
method (Omura and Sato 1964) and a double-beam spectrophotometer (UV2100PC, 
Shimadzu, Japan). The enzyme (in 10 mM potassium phosphate buffer, pH 7.4 
containing 20% glycerol) was reduced with a few grains of sodium dithionite and 
divided into two cuvettes to record a base line between 400 and 500 nm. Then the 
sample cuvette was bubbled gently with carbon monoxide for 1 minute and a spectrum 
was recorded. The concentration of functional CYP264B1 was calculated according to 
the Beer–Lambert equation: 
CP450 :                 concentration of cytochrome P450 [mM] 
 ∆A450-490            absorptional difference at 450 nm and 490 nm 
fd                         dilution factor 
                          millimolar extinction coefficient [91 mM-1×cm-1] 
d                          diameter or length of the cuvette [cm] 
d
f
C dP
×
×∆Α
=
−
ε
490450
450
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2.2.5. Determination of redox partners for CYP264B1
Redox partner determination was carried out based on the difference spectra described 
by Omura and Sato (Omura and Sato 1964). In these experiments, the heme iron of 
CYP264B1 (2 µM) was reduced by NADPH (1 mM) instead of dithionite in the 
presence of various redox proteins as electron transfer mediators. During this 
experiment, the redox proteins from So ce56 (5 ferredoxins and 2 ferredoxin 
reductases), from bovine adrenal (truncated adrenodoxin (Adx4-108) and adrenodoxin 
reductase (AdR)) were tested. Different combinations of ferredoxin and ferredoxin 
reductase were analysed. The combinations giving a peak maximum at 450 nm were 
identified as suitable redox partners of CYP264B1. 
2.2.6. Substrate determination  
2.2.6.1. Substrate determination for CYP264B1 and analysis of substrate binding 
A substrate binding assay (based on the occurrence of a type I shift) was used to screen 
potential substrates for CYP264B1. The experiment was carried out at 25°C under 
aerobic conditions on a double-beam spectrophotometer (UV2100PC, Shimadzu, Japan) 
equipped with two tandem quartz cuvettes (Hellma, Müllheim, Germany). In each 
cuvette, one chamber contained 2 M CYP264B1 in 10 mM potassium phosphate 
buffer, pH 7.4, containing 20% glycerol, and the other chamber contained buffer. The 
substrate dissolved in DMSO was added equally (<2 l) in a final concentration of 5 
M into the chamber containing the enzyme in case of the sample cuvette and into the 
chamber containing only buffer in case of the reference cuvette, respectively. After 5 
min, spectra were recorded between 360 nm and 500 nm. Compounds causing a type I 
shift of the CYP264B1 spectrum were considered as potential substrates and used for 
enzyme activity assays. 
For the determination of the binding constant (Kd) to CYP264B1, substrate was titrated 
into enzyme solution containing 4 µM CYP264B1 until the enzyme became saturated 
with substrate. The peak-to-trough difference was plotted against substrate 
concentration and fit into a nonlinear tight binding quadratic equation (Williams and 
Morrison 1979) using Origin 8.1 software. All titrations were carried out three times 
and the final values are the mean of the three experimental data sets. 
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2.2.6.2. Substrate determination for GeoA 
An in vitro assay was used to determine the substrate for GeoA. Universal substrates of 
terpene cyclases (GPP, FPP, GGPP) were tested. The in vitro assay was carried out in a 
volume of 500 µl of 10 mM potassium phosphate buffer (pH 7.4) containing GeoA (3 
µM), substrate (50 µM) and MgCl2 (10 mM). Reactions were incubated for 1 hour at 
30°C in a thermomixer (Eppendorf) under constant shaking. Reactions were stopped by 
adding 500 µl of n-hexan and thoroughly mixing of the samples. Extraction was done 
twice with 2 volumes of n-hexan. The n-hexan phases were pooled and concentrated to 
100 µl in a vacuum-drier (SpeedVac Concentrator 5301, Eppendorf) before they were 
analysed by GCMS.  
2.2.7. In vitro conversion 
2.2.7.1. In vitro conversion with CYP264B1 
The in vitro reconstitution standard assays for substrates were carried out in a final 
volume of 500 µl in 10 mM potassium phosphate buffer, pH 7.4, 20% glycerol. The 
reaction mixture contained 2 µM CYP264B1, 200 µM substrate, 40 µM Adx4-108, 2 µM 
AdR and a NADPH regenerating system consisting of 5 mM glucose-6-phosphate, 1 U 
glucose-6-phosphate dehydrogenase, and 1 mM MgCl2. Reactions were initiated by the 
addition of 0.1 mM NADPH. After incubation at 30°C for 30 min in a thermomixer 
(Eppendorf), reactions were stopped by adding 500 µl chloroform. The samples were 
extracted twice and the extracts dried in a vacuum-drier. The residuals were dissolved in 
200 µl acetonitrile or 50 µl ethylacetate for HPLC or TLC monitoring, respectively. 
2.2.7.2. In vitro conversion with GeoA 
The in vitro assay was described previously, in the section 2.2.6.2  
2.2.7.3. In vitro conversion with GeoA and CYP264B1 
The in vitro assays for substrates (FPP, GGPP) were carried out in a final volume of 500 
µl in 10 mM potassium phosphate buffer, pH 7.4, 20% glycerol. In general, this reaction 
mixture contained the combined components from the two reaction systems of 
CYP264B1 and of terpene cyclase as described above: CYP264B1 (2 µM), GeoA (10 
µM), substrate (125 µM), Adx4-108 (40 µM), AdR (2 µM) and a NADPH regenerating 
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system consisting of 5 mM glucose-6-phosphate, 1 U Glucose-6-phosphate 
dehydrogenase, 10 mM MgCl2. The reaction of CYP264B1 was initiated by addition of 
0.1 mM NADPH. After incubating at 30°C for 1 hour in a thermomixer, reactions were 
stopped by adding 500 µl chloroform, extracted twice and dried in a vacuum-drier. The 
residuals were dissolved in 100 µl ethyl acetate or 10 µl n-hexan for GCMS or TLC 
monitoring, respectively. 
2.2.8. Kinetic analysis of CYP264B1 
For enzyme kinetic experiments, substrate concentrations were varied in the range of 0-
400 µM (nootkatone) and 0-200 µM (α-and β-ionone), respectively. All other 
components were fixed as in the standard assay and reactions were carried out as 
described in 2.2.7.1. After 5 minutes, the reactions were stopped, extracted twice using 
chloroform and dried in a vacuum-drier. The residuals were dissolved in 100 µl 
acetonitrile and injected onto HPLC. Product quantification was performed by 
correlating the peak area of the respective product(s) with the combined peak area of the 
product(s) and the substrate. The product formation was plotted against the respective 
substrate concentration and fitted to the hyperbolic curve f(x) = ax/(b+x) (Michaelis – 
Menten kinetics) using the program SigmaPlot 9.0 to determine the values for the Vmax
and Km; standard deviations were derived from 3 independent experiments.  
2.2.9. In vivo substrate conversion with CYP264B1 
In vivo conversion was carried out for β-ionone. A single colony of E. coli C43(DE3) 
carrying plasmid pETC4AA was cultivated in LB medium containing Amp (100 µg/ml) 
at 37°C overnight under constant shaking. The overnight culture was used to inoculate 
(1% v/v) 50 ml of TB medium in a 300 ml baffled flask and grown at 37°C under 
constant shaking until the OD600 reached 0.6-1.0. After the culture was induced by 
addition of 1 mM of IPTG and supplemented with 0.5 mM δ-Ala it was further 
incubated at 30°C under constant shaking. After 24 hours, a stock solution of substrate 
dissolved in ethanol (1 M) was added to the culture to a final concentration of 300 µM 
and incubated for another 24-48 hours. 
To analyze the in vivo conversion, aliquots of 0.5 ml culture were centrifuged to remove 
the cells. The supernatant was extracted twice with chloroform. The organic phase was 
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then evaporated in a vacuum-drier. The residuals were dissolved in 200 µl chloroform 
or 50µl ethyl acetate for HPLC or TLC analysis, respectively. 
2.2.10. Terpenoid production in mevalonate pathway-engineered E. coli 
2.2.10.1. Terpene production with GeoA 
E. coli C43(DE3) carrying plasmids pETG and pAC-Mev (or pAC-Mv) was precultured 
in TB medium containing Amp (100 µg/ml) and chloramphenicol (Cm, 30 µg/ml) at 
37°C overnight under constant shaking. The overnight culture was used to inoculate 
(1% v/v) 30 ml TB medium containing Amp and Cm in a 50-ml flask. The culture was 
grown at 37°C under constant shaking. When the OD600 reached 0.6-1.0, 1mM IPTG 
and 0.5 mg/ml of D-mevalonolactone (Sigma, Germany) were added and the cells were 
further cultivated at 27°C under constant shaking. After 3 hours, the culture was 
overlaid with 10 ml decane (Sigma, Germany) and incubated for another 48 - 72 hours 
under constant shaking. Aliquots of 100 µl of the overlaid - decane phase were then 
taken for GCMS analysis.  
2.2.10.2. Terpene production with GeoA and CYP264B1
E. coli C43(DE3) carrying plasmids pETC4AAG and pAC-Mev (or pAC-Mv) or 
plasmids pAC-MvC4 and pAAG was precultured in TB medium containing Amp (100 
µg/ml)  and Cm (30 µg/ml)  at 37°C for overnight under constant shaking. The 
overnight culture was used to inoculate (1% v/v) 50 ml TB medium containing Amp 
and Cm in a 300-ml-baffle flask. The culture was grown at 37°C under constant 
shaking. When the OD600 reached 0.6-1.0, 1mM IPTG and 0.5 mg/ml of D-
mevalonolactone, 0.5 mM of δ-Ala, 1.13% (w/v) of hydroxypropyl-β-cyclodextrin 
(Sigma) were added and the cells were further cultivated at 30°C for another 48 hours 
with shaking. Aliquots of 0.5 ml of the culture were centrifuged to remove the cells. 
The supernatant were extracted twice using 1 ml chloroform. The chloroform phases 
were then evaporated in a vacuum-drier. The residuals were dissolved in 50 µl ethyl 
acetate or 100 µl n-hexan for TLC or GC-MS analysis, respectively. 
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2.2.11. Product purification and identification 
2.2.11.1. Silicagel column 
In this work, a silicagel column was used to purify the products of β-ionone and 
nootkatone conversion. Products were prepared in an up-scaled in vitro reaction of 250 
ml. Reactions were carried out in an incubator at 30°C under constant shaking. After 2 
hours, reaction mixtures were extracted twice using 2 volumes of chloroform. The 
chloroform phases were then collected and evaporated in a rotary vacuum system 
(Büchi Rotavapor R-114). The residuals were dissolved in ethyl acetate and passed 
through a silica gel column (35-70 µM particle size, 1,5 cm x 60 cm) using n-
hexan/ethyl acetate (3:2) as eluent. Fractions were checked by TLC as described below 
(section 2.2.11.2). The fractions containing the product were combined and dried in a 
vacuum-drier. 
2.2.11.2. Thin layer chromatography 
TLC was used as a preliminary method to monitor the presence of compounds in the 
substrate conversion as well as to determine appropriate solvents for the purification 
using a silica gel column. Samples were spotted onto TLC aluminum plates (Silica Gel 
60 F254, Fluka). The plates were developed in a solvent tank containing n-hexane/ethyl 
acetate. Different ratios of n-hexane/ethyl acetate were investigated to find out the 
appropriate developing solvent for each compound. After developing, the TLC plates 
were dried and visualized first at 254 nm (UV light). Then, plates were stained with a 
vanillin solution 1 % (w/v) in ethanol and sulfuric acid (95:5) and subsequently heated 
for 2 min at 110°C to visualize again. 
2.2.11.3. High performance liquid chromatography 
High performance liquid chromatography (HPLC) was used to analyze the substrate 
conversion. Aliquots of 0.5 ml of the substrate conversion were extracted with 
chloroform. The organic phases were evaporated in a vacuum-drier. The obtained 
residuals were dissolved in 200 µM acetonitrile and applied onto a HPLC system 
(LC900, Jasco, Germany) using a reversed phase C18 column (Macherey-Nagel 
CC125/4 Nucleodur 100-5) and an isocratic solvent system containing acetonitrile/water 
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(55:45). A flow rate 1 ml min-1 was used. The products and substrates were monitored at 
254 nm. 
2.2.11.4. Gas chromatography-mass spectrometry 
The products of the conversion by terpene cyclase were analyzed via gas 
chromatography-mass spectrometry (GC-MS). GC-MS analysis was performed by 
Dominik Pistorius, Department of Pharmaceutical Biotechnology, Saarland University 
on an Agilent 6890N Network GC-System combined with a 5973 Network Mass 
Selective Detector and a DB-WAX column (0.25 mm x 0.25 mm x 30 m, J&W 
Scientific) under the following conditions: EI 70 eV, source temperature 200 °C; carrier 
gas He; injection temperature 250 °C, interface temperature 300 °C; flow rate 1.0 
ml/min, constant flow mode; splitless injection, column temperature program: Start at 
50°C, hold for 1 min, then ramp to 150°C, 4°C/min, ramp to 300°C, 15°C /min, hold for 
5 min, then ramp to 50°C, 15°C/min. All products were identified by comparison of 
their EI-MS spectra with those of the National Institute of Standards and Technology 
(NIST MS Search 2.0). 
The products of the terpene cluster encoding enzymes were also analyzed via GC-MS. 
Measurements were performed by Nils Günnewich at CNRS-Strasbourg; on an Agilent 
6890N (GC) and Agilent 5973N (MS) instrument under the following conditions: EI 70 
eV with a scan width of m/z 50-600, source temperature 250°C, column DB-5ms or HP-
5ms (both Agilent Technologies); injection temperature 250°C, interface temperature 
250°C (200°C); carrier gas He, flow rate 1.2 ml/ min., constant flow mode; splitless 
injection, column temperature program: 50°C hold for 0.5 min, then raised to 320°C at a 
rate of 10°C/min and then hold 5 min (which is in total 32.5 min). All products were 
identified by comparison of their EI-MS spectra with those of the NIST MS search 2.0. 
2.2.11.5. Nuclear magnetic resonance spectroscopy 
Nuclear magnetic resonance spectroscopy (NMR) was used to characterize the products 
of nootkatone and β-ionone conversions. NMR analysis was performed by Dr. Josef 
Zapp, Department of Pharmaceutical Biology, Saarland University. Ten milligrams of 
the products were prepared and used for 1H and 13C NMR with a Brucker DRX 500 
NMR spectrophotometer. The spectra were recorded in CDCl3. All chemical shifts are 
reported using the standard δ notation in parts per million (ppm). 
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2.2.12. Homology modeling and substrate docking into CYP264B1 active site 
The homology modeling and substrate docking were performed by Dr. Michael C. 
Hutter, Center for Bioinformatics, Saarland University. P450eryF (CYP107A1) from 
Saccharopolyspora erythreae (accession code Q00441) shows a sequence identity of 
30% to CYP264B1 of So ce56. The corresponding crystallographic structure (pdb entry 
1Z8P) was chosen as a structural template using the automated mode of SWISS-
MODEL (Arnold et al. 2006; Guex et al. 1997; Schwede et al. 2003). The coordinates 
of the heme-porphyrin atoms from the template structure were added subsequently to 
the obtained homology model. No further structural refinement of the model was 
performed, since the carboxylate groups of the heme formed ionic hydrogen-bonds with 
the side chains of Arg91, Arg287, and His343. Comparison of the obtained model with 
the template structure showed deviations only in the outer regions, whereas the region 
around the active center was strongly conserved. Compounds for docking were 
generated manually and energetically optimized using the MM+ force field as 
implemented in HYPERCHEM (version 6.02, Hypercube Inc., Gainsville FL, 1999). 
The program AUTODOCK (version 4.00) (Huey et al. 2007; Morris 1998) was applied 
for docking of  α-ionone (R- and S-isomer), β-ionone, and (+)-nootkatone into the 
homology model. The Windows version 1.5.2 of Autodock Tools was used to compute 
Kollman charges for the enzyme and Gasteiger-Marsili charges for the ligands (Sanner 
1999). A partial charge of +0.400 e was assigned manually to the heme-iron, which 
corresponds to Fe(II) that was compensated by adjusting the partial charges of the 
ligating nitrogen atoms to –0.348 e. Flexible bonds of the ligands were assigned 
automatically and verified by manual inspection. A cubic grid box (54 x 54 x 54 points 
with a grid spacing of 0.375 Å) was centered 5 Å above the heme-iron. For each of the 
ligands 150 docking runs were carried out applying the Lamarckian genetic algorithm 
using default parameter settings, except for the mutation rate that was increased to 0.05. 
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3. RESULTS 
3.1. Expression and characterization of CYP264B1 
3.1.1. Protein expression and purification  
The gene coding for CYP264B1 in pET17b was expressed in E. coli BL21(DE3). To 
monitor the expression level, different temperatures (25°C, 28°C, 30°C, 32°C, 35°C, 
37°C) were investigated. After 48 h of expression, cells were harvested, disrupted by 
sonification and centrifuged as described in section 2.2.3. The expression levels were 
calculated based on the reduced CO difference spectrum method (Omura and Sato 
1964) for the crude extract enzyme from the supernatant. The result showed that the 
expression level was even less than 5 nmol L-1 E. coli culture for all tested temperatures 
as mentioned above (data not shown). However, when temperature was decreased to 
20°C, the expression level could be increased up to 257 nmol L-1 E. coli culture. 
Moreover, co-expression of CYP264B1 with the chaperones GroES and GroEL at 28°C 
further improved the level of protein expression, leading to a yield of 820 nmol L-1 E. 
coli culture. After affinity (IMAC) and size exclusion chromatography, the yield of the 
purified protein was 511 nmol L-1. Purity of protein was estimated by SDS-PAGE and 
the protein molecular weight was found to correspond well to the predicted value of 47 
kDa (Figure 3.1). 
Figure 3.1: SDS-PAGE of CYP264B1. Lane 1 - prestained protein marker (BioLabs); 
Lane 2 and 3 - purified protein 
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3.1.2. Spectrophotometric characterization 
To spectrophotometrically characterize CYP264B1, purified enzyme in potassium 
phosphate buffer (pH 7.4) containing 20% glycerol was measured in the UV-visible 
region from 300 to 700 nm. The result showed that the oxidized form of CYP264B1 
exhibited a major (γ) Soret peak at 417 nm and smaller  α and β bands at 567 nm and 
533 nm, respectively (Figure 3.2), indicating that the protein was purified in its low-spin 
state. The dithionite reduced spectrum of CYP264B1 also showed the absorption 
maximum of the Soret band at 417 nm (Figure 3.2). The carbon monoxide bound form 
gave a typical peak maximum at 450 nm and a dominating shoulder at 420 nm (Figure 
3.2). During a time interval of 0.5 min, the peak at 420 nm increased corresponding 
with the simultaneous decrease of the peak at 450 nm (Figure 3.3), which implied 
certain instability of CYP264B1 in its reduced form by dithionite. 
Figure 3.2: UV-visible spectra of CYP264B1. UV-visible absorption spectrum of 
oxidized (black, solid line), dithionite reduced (gray line), and reduced CO complexed 
(dashed with dotted line) enzyme. The inset shows a magnification of the spectrum in 
the / band region. 2 µM CYP264B1 was used 
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Figure 3.3: CO-difference spectra of CYP264B1. The time dependent development of 
the peak at 420 nm at 450 nm is shown. Red, green, blue, pink, cyan, dark red, dark 
green, dark yellow, dark blue, dark pink, dark cyan, dark gray line are CO-difference 
spectra of CYP264B1 at 0.5; 1; 1.5; 2; 2.5; 3; 3.5; 4; 4.5; 5; 5.5; 6 min, respectively 
3.1.3. Redox partners  
Most P450s perform their chemical reactions after receiving reduction equivalents from 
NADPH or NADH through electron transfer partners (Hannemann et al. 2007). Thus, 
the identification of the redox partners is the primary step necessary to characterize 
CYP264B1. In this work, 5 ferredoxins (Fdx1, Fdx2, Fdx3, Fdx5, Fdx8) and 2 
ferredoxin reductases (FdRA and FdRB) from So ce56, as well as adrenodoxin (Adx4-
108) and adrenodoxin reductase (AdR) from bovine adrenals were tested. Based on the 
CO-difference spectral method, various ratios and combinations of these autologous 
electron transfer proteins were tested as potential redox partners for CYP264B1. 
However, only with the combinations of Fdx2-FdRB and Fdx8-FdRB, a very low peak 
of the CO difference spectrum at 450 nm was observed (data not shown). In constrast, 
in the presence of the heterologous redox partners Adx and AdR, the typical CO-
difference peak was observed with NADPH as electron donor. Reduction in this case 
occurs slower but the protein is more stable than upon the reduction by dithionite 
(Figure 3.4).  
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Figure 3.4: CO-difference spectra of CYP264B1 using NADPH in combination 
with Adx and AdR as reducing agent. The time dependent development of the peak at 
420 nm at 450 nm is shown. Red, blue, green, dark gray, dark cyan, dark pink, black, 
dark green, dark red, pink, dark yellow are CO-difference spectra of CYP264B1 at 0.5; 
1; 1.5; 2; 2.5; 3; 3.5; 4; 4.5; 5; 5.5 min, respectively. Optimal NADPH reduction was 
observed with the concentraion of CYP264B1:Adx:AdR of 2 µM:40 µM:2 µM  
3.1.4. Substrate screening  
It has been shown that substrates can bind to the active site of the cytochrome P450 and 
displace the heme water ligand thereby causing a shift in the ferric heme iron from low-
spin towards high–spin, which induces a so-called type I spectrum with the Soret 
absorption minimum around 420 nm and a maximum at about 390 nm (Denisov 2005; 
Lewis 2001). Based on this principle, 22 compounds (their structures are illustrated in 
Appendix) belonging to 9 groups (monoterpenoids, sesquiterpenoids, norisoprenoids, 
diterpene acids, steroids, fatty acids, and ketons and aroma related compounds) were 
investigated with regard to their ability to induce a spin-shift of CYP264B1 (Table 3.1). 
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Table 3.1: Screening of potential substrates for CYP264B1 
(++) A clear spin shift was observed, (+) a slight spin shift was observed, (NS) no shift was observed. 
Compound group Name Type I shift 
Monoterpenoid Camphor + 
Nootkatone ++ 
Valencene ++ 
Isolongifolene-9-one ++ 
Clovene ++ 
Humulene ++ 
α-longipinene ++ 
Sesquiterpenoid 
Copaen ++ 
α-ionone ++ Norisoprenoid 
β-ionone ++ 
Abietic acid NS Diterpenoid 
Gibberellin A3 + 
Keton Santonin NS 
Aroma Coumarin + 
 7-ethoxy-coumarin + 
Corticosterone + 
Progesterone NS 
Testosterone NS 
Steroid 
17-α-methyl-testosterone NS 
Palmitic acid NS 
Myristic acid NS 
Fatty acid 
Stearic acid NS 
Among 22 investigated compounds, the sesquiterpenes (valencene, nootkatone, 
humulene, copaen, clovene, longipinene, isolongifolene-9-one) and the norisoprenoids 
(α-ionone, β-ionone) resulted in clear type I shifts of CYP264B1. Also with some of the 
other compounds (camphor, coumarin, gibberelline, santonin, corticosterone, 
progesterone), a slight type I shift was observed (Table 3.1 and Figure 3.5). 
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Figure 3.5: Substrate screening based on type I shift of CYP264B1.  The interaction 
between 15 compounds and CYP264B1 are shown. The substrate dissolved in DMSO 
was added (final concentration of 5 µM) to a solution of CYP264B1 (2 M) in 10 mM 
potassium phosphate buffer pH 7.4 containing 20% glycerol using tandem cuvettes as 
described in the section 2.2.6.1. Sesquiterpenes (clovene, copaene, humulene, 
isolongifolene-9-one, longipinene, nootkatone, valencene) and the norisoprenoid β-
ionone (illustrated in solid lines), show a clear type I shift 
3.1.5. Substrate binding constant 
Because of the high selectivity of hydroxylation caused CYP264B1 (see section 3.1.6 
below), only the products of α-/β-ionone and nootkatone hydroxylation were further 
characterized. In the type I binding, the spectral change depends on substrate 
concentration in relation to the enzyme concentration. Therefore, the dissociation 
constant (Kd) value of substrate and P450 can be determined based on this 
characteristic. In this work, the interactions between three compounds (α-ionone, β-
ionone and nootkatone) and CYP264B1 were studied. The substrates were stepwise 
added to 4 µM enzyme until the enzyme became saturated. The peak-to-trough 
difference was plotted against substrate concentration and fit into a nonlinear tight 
binding quadratic equation (Williams and Morrison 1979) using Origin 8.1 software. 
The result showed that both the α- and β-ionone-bound form of CYP264B1 gave a peak 
at 393 nm and a trough at 426 nm. The ionones showed a tight binding with Kd values 
of 1.79 ± 0.13 µM for α-ionone and 2.11 ± 0.14 µM for β-ionone, respectively (Figures 
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3.6 a and b). The nootkatone-bound form of CYP264B1 gave a peak at 390 nm and a 
trough at 424 nm. This substrate also showed a tight binding with a Kd value of 1.21 ± 
0.13 µM (Figure 3.6 c). 
Figure 3.6 a: Spectral changes of CYP264B1 induced by various concentrations of 
α- ionone. The inset illustrates spectral shifts induced by α-ionone binding to 
CYP264B1 
Figure 3.6 b: Spectral changes of CYP264B1 induced by various concentrations of 
β-ionone. The inset illustrates spectral shifts induced by β-ionone binding to 
CYP264B1 
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Figure 3.6 c: Spectral changes of CYP264B1 induced by various concentrations of 
nootkatone. The inset illustrates spectral shifts induced by nootkatone binding to 
CYP264B1 
3.1.6. Substrate conversion 
In vitro conversions were carried out for all compounds inducing type I shifts of 
CYP264B1 (see section 3.1.4). Reactions were performed at 30°C as described in the 
section 2.2.7.1. After an incubation time of 1 hour, reactions were stopped by adding 
500 µl chloroform. Products were extracted twice with chloroform and dried in a 
vacuum-drier. Product formations were monitored by TLC (see section 2.2.11.2) or 
HPLC (see section 2.2.11.3).  
3.1.6.1. Conversion of α-ionone 
The in vitro conversion of α-ionone by CYP264B1 was analyzed via HPLC. The 
chromatogram showed that CYP264B1 converted α-ionone into a single product found 
at a retention time of 2 min. This product was compared with the authentic 3-hydroxy-
-ionone (Khatri et al. 2010) and finally confirmed as 3-hydroxy--ionone (Figure 3.7). 
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Figure 3.7: Conversion of  α-ionone by CYP264B1. HPLC chromatogram of α-
ionone conversion into 3-hydroxy-α-ionone; the conversion of substrate is shown in 
black line; the negative control without NADPH is shown in gray line 
3.1.6.2. Conversion of β-ionone 
The conversion of β-ionone also resulted in a single product with a retention time of 2 
min (Figure 3.8). Since no authentic hydroxylated product of β-ionone was available for 
comparison, the identification of the product was performed by NMR. To obtain a 
sufficient quantity of product for NMR analysis, the in vitro conversion was performed 
in a volume of 250 ml using crude extract enzyme. Under these conditions, another non-
specific product was formed, which was also present in the negative control (crude 
extract of E. coli containing only Adx, only AdR or only CYP264B1) and detected at a 
retention time of 3 min (data not shown). After purification via a silicagel column, the 
CYP264B1-specific product was characterized by NMR. The 1H and 13C spectra 
revealed the structure of a monohydroxylated β-ionone and confirmed it as 3-hydroxy-
β-ionone. 
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Figure 3.8: Conversion of β-ionone by CYP264B1. HPLC chromatogram of β-ionone 
conversion into 3-hydroxy-β-ionone; the conversion of substrate is shown in black line; 
the negative control without NADPH is shown in gray line. Asterisk represents artifact 
The detailed NMR data for 3-hydroxy-β-ionone were obtained as: 1H NMR: (CDCl3, 
500 MHz),  1.09, s, 3H (H-12); 1.10, s,3H (H-11); 1.47, dd,  J= 12 and 12 Hz (H-2a); 
1.75, s; 3H (H-13), 1.77, ddd; J= 12, 3.5 and 2 Hz (H-2b); 2.06, dd, J= 17.5 and 9.5 Hz 
(H-4a); 2.28, s, 3H (H-10); 2.4,1 brdd,  J= 17.5 and 6 Hz (H-4b); 3.99, dddd, J= 12, 9.5, 
6 and 3.5 Hz (H-3); 6.09, brd, J= 16.5 Hz (H-8); 7.19, brd, J= 16.5 Hz (H-7). 13C NMR 
(CDCl3, 125 MHz),  21.58 (C-13), 27.31 (C-10); 28.56 (C-12); 30.06 (C-11), 36.91 (C-
1); 42.74 (C-4); 48.39 (C-2); 64.54 (C-3); 132.22 (C-5); 132.39 (C-8); 135.63 (C-6); 
142.3 (C-7); 198.53 (C-9). 
3.1.6.3. Conversion of (+)-nootkatone 
The conversion of nootkatone by CYP264B1 revealed a major product (77%) at 2.3 min 
and a minor product (13%) at 3.5 min (Figure 3.9). Similar to β-ionone, no authentic 
hydroxylated product of nootkatone was available for comparison; thus the 
identification of the product was performed by NMR. Again a large-scale conversion in 
a volume of 250 ml using crude extract enzyme was carried out. Both, the major and 
minor product previously found in the conversion using purified enzyme, were detected 
in this case. However, the minor product was also present in the control experiment 
where crude extract of cells containing only Adx, AdR or CYP264B1 was used. 
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Therefore, only the major product was further characterized. After purification via a 
silicagel column, the major product was identified as 13-hydroxy-nootkatone by NMR. 
Figure 3.9: Conversion of nootkatone by CYP264B1. HPLC chromatogram of 
nootkatone conversion into 13-hydroxy-nootkatone; the conversion of substrate is 
shown in black line; the negative control without NADPH is shown in gray line. 
Asterisk represents the minor product 
The detailed NMR data for 13-hydroxy-nootkatone are: 1H NMR: (CDCl3; 500 MHz) 
0.95, d, J= 7 Hz, 3H (H-14); 1.11, s, 3H (H-15); 1.15, dd, J= 13.5 and 13.5 Hz (H-9b); 
1.36, m (H-8b); 1.96, m (H-8a); 2.01, m (H-9a); 2.02, m (H-4); 2.22, m (H-3b); 2.29, m 
(H-3a); 2.37, m (H-6b); 2.43, m (H-7); 2.52, m (H-6a); 4.14, s, 2H (H-14); 4.90, s (H-
12b); 5.07, s (H-12a); 5.76, brs (H-1). 13C NMR (CDCl3; 125 MHz)  14.90 (C-14); 
16.80 (C-15), 32.11 (C-8); 33.07 (C6); 36.05 (C-7); 39.44 (C-5); 40.42 (C-4); 42.06 (C-
3); 44.42 (C-9); 65.32 (C-13); 109.19 (C-12); 124.82 (C-1); 152.56 (C-11); 170.07 (C-
10); 199.54 (C-2). HMBC: (effects only for the methylene protons H-3, H-6, H-8 and 
H-9): H-3a to C-2, C-4, C-5 and C-14; H-3b to C-1, C-2, C-4, C-5 and C-14; H-6a to C-
5 and C-7; H-6a to C-5, C-7 and C-15; H-6b to C-4, C-5, C-7, C-8, C-11 and C-15; H-
8a/H-8b to C-9 and C-10; H-9a to C-1, C-8 and C-10; H-9b to C-1, C-7, C-8 and C-10.  
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3.1.6.4. Conversion of other sesquiterpenes 
Among 7 tested sesquiterpenes (valencene, nootkatone, humulene, copaen, clovene, 
longipinene, isolongifolene-9-one), only copaene was not converted by CYP264B1. The 
enzyme was able to convert valencene into 5 products with retention factors (Rf) of 
0.17, 0.37, 0.53, 0.67, 0.95 on TLC (n-hexan/ethylacetate: 4/1), α-longipinene into 1 
product with Rf of 0.88 on TLC (n-hexan/ethylacetate: 3/2), clovene into 1 main product 
with Rf of 0.83 on TLC (n-hexan/ethylacetate: 3/2), α-humulene into 1 main product 
with Rf of 0.83 on TLC (n-hexan/ethylacetate: 3/2) (Figure 3.10) and isolongifolene-9-
one into 1 product with Rf of 0.22 on TLC (n-hexan/ethylacetate: 3/2) and retention 
time of 2 min on HPLC (acetonitrile/water: 55/45) (Figure 3.11). Products of these 
substrate conversions have not yet characterized due to lack of time.  
Figure 3.10: Conversion of of sesquiterpene compounds by CYP264B1 visualized 
on TLC using vallinin staining solution as described in the section 2.2.11.2. Conversion 
of valencene (a); α-longipinene (b); clovene (c); humulene (d). Lane 1- negative control 
without NADPH; Lane 2- conversion with NADPH  
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Figure 3.11: Conversion of isolongifolene-9-one by CYP264B1. TLC (a): Lane 1 - 
negative control without NADPH; Lane 2 - conversion with NADPH. HPLC (b) dotted 
black line is the negative control without NADPH, dark pink line is the conversion with 
NADPH. Arrows represent formed product (P). S - substrate, asterisk – artifact 
3.1.7. Enzyme kinetics 
Catalytic activity of CYP264B1 was further characterized by enzyme dependent 
substrate conversion as described in the section 2.2.8. Activity of CYP264B1 was 
reconstituted with the heterologous redox partners, Adx and AdR. The ratio of 
CYP264B1/Adx/AdR was 2:20:1. Substrate concentrations were varied in the range of 
0-400 mM (nootkatone) and 0-200 mM (α-and β-ionone). Reaction was carried out in a 
thermal shaker at 30oC for 5 min. Assuming the absorbance properties of the products 
and substrate are the same, product quantification was performed by correlating the 
peak area of the respective product(s) with the combined peak area of the product(s) and 
the substrate. Product amount was plotted against the respective substrate concentration 
and fitted to the hyperbolic equation (f(x) = ax/(b+x)); standard deviations were derived 
from 3 independent experiments. Results are shown in Figure 3.12. 
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Figure 3.12 a: Determination of kinetic parameters for  α-ionone conversion 
catalyzed by CYP264B1  
Figure 3.12 b: Determination of kinetic parameters for  β-ionone conversion 
catalyzed by CYP264B1 
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Figure 3.12 c: Determination of kinetic parameters for  nootkatone conversion 
catalyzed by CYP264B1 
For conversion of α-ionone into 3-hydroxy-α-ionone by CYP264B1, a Km value of 64.5 
± 8.4 µM and a Vmax value of 6.19 ± 0.33 nmol product per minute per nmol CYP264B1 
were determined (R2= 0.96) (Figure 3.12 a). Similar values were also obtained for β-
ionone (Km and Vmax values of 72.72 ± 11.43 µM and 4.95 ± 0.33 nmol product per 
minute per nmol CYP264B1, respectively (R2= 0.96) (Figure 3.12 b). Since the 
conversion of nootkatone gives one major and one minor product, the catalytic activity 
was calculated for the total product formation taking into account both products, with 
Km and Vmax values of 75.34 ± 12.57 µM and 12.56 ± 0.71 nmol product per minute per 
nmol CYP264B1, respectively (R2= 0.95) (Figure 3.12 c). 
3.1.8. Homology modeling and substrate docking 
To get a deeper insight into the structural basis for the selectivity of hydroxylation, a 
homology model of CYP264B1 was produced and the substrates were docked into this 
model using AUTODOCK. Both the R- and S-isomer of α-ionone bind in an orientation 
that has the 3-position in a suitable distance to the heme-iron for hydroxylation, thus 
being in excellent agreement with the experimental results. Although the distance is 
shorter for the R-isomer (2.77 Å) than for the S-isomer (3.25 Å), the corresponding pose 
of the former is adopted less often than that of the S-isomer. The energetically most 
favorable docking position of ionone is likewise that showing the 3-position closest for 
hydroxylation (3.96 Å). In all conformations found for α-ionone and β-ionone that 
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allow hydroxylation in 3-position, the carbonyl oxygen is within hydrogen-bond 
distance to the hydroxyl group of Thr285. Moreover, these poses found suggest that 
hydroxylation is stereo-selective (Figure 3.13 a). 
The most often adopted pose of (+)-nootkatone has the 13-position in a distance of 2.81 
Å to the iron, whereby its carbonyl oxygen forms a hydrogen-bond with the backbone 
nitrogen of Met286. This corresponds to the major product confirmed experimentally. 
The docking position shows nootkatone oriented with the carbonyl oxygen towards the 
iron. Therefore, it is unlikely that the observed minor product is formed from this pose. 
Instead, it could be formed after reorientation of 13-hydroxy-nootkatone within the 
binding pocket, or after dissociation and rebinding in a different orientation (Figure 3.13 
b). 
Figure 3.13: Obtained docking positions in the homology model of CYP264B1. The 
R-isomer of α-ionone is shown in pink, the S-isomer in cyan, and the β-ionone in 
orange. Likewise color coded are the distances (given in Ångstrom) between the 
hydroxyl oxygen of Thr285 and the carbonyl oxygens of the ionones, as well as 
between the 3-position and the heme iron, respectively (a). Distances (given in 
Ångstrom) are shown between the backbone nitrogen of Met286 and the carbonyl 
oxygen of nootkatone, as well as between position C-13 of nootkatone and the heme 
iron (b) 
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3.1.9. E. coli whole cell conversion for CYP264B1 substrate 
Since CYP264B1 was able to convert diverse sesquiterpene compounds, it is an 
attractive candidate to produce new sesquiterpene derivatives. For this purpose, using 
the isolated enzyme is not the solution of choice due to the high costs of pyridine 
nucleotide cofactors as well as the laborious protein purification steps. We therefore 
constructed a whole cell system for the conversion of CYP264B1 substrates. Genes 
coding for CYP264B1, Adx and AdR were introduced into vector pET17b, contructing 
the tricistronic vector pETC4AA. This vector was transformed into E. coli C43(DE3), 
which was subsequently tested for in vivo conversion of β-ionone 24 hours after 
induction, β-ionone was added to the culture at a final concentration of 300 µM and 
incubation was continued. After another 22 and 48 hours, aliquots of 0.5 ml culture 
were centrifuged to remove the cells. The supernatant was extracted with chloroform 
and the bioconversion was analyzed by HPLC as described in the section 2.2.9. HPLC 
analyses of the in vivo β-ionone conversion are shown in Figure 3.14. 
Figure 3.14: HPLC of β-ionone product. The red line and the green line indicate the 
product formation from the in vitro and in vivo conversion, respectively 
As shown in Figure 3.14, in the in vivo conversion of β-ionone by CYP264B1 (green 
line), two products were formed. Comparison with the in vitro conversion (red line) 
showed that the specific product of CYP264B1 (3-hydroxy-β-ionone) was formed and 
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could be detected at a retention time of 2 min. However, in the in vivo conversion, 
besides 3-hydroxy-β-ionone product, another product with a retention time of 3 min was 
also found. In the control of E. coli carrying pETC4, only this side product was 
observed (Figure 3.15). This result indicated that 3-hydroxy-β-ionone is the sole 
product of CYP264B1 and that the side product is produced by other enzymes of this 
strain. Yield of 3-hydroxy-β-ionone was estimated to be 48 mg/L culture per day. In 
addition, Figure 3.16 shows that the product level after 48 hours was nearly similar to 
the level after 24 hours and the side product peak has dissappered. This result indicated 
that the maximum yield of 3-hydroxy-β-ionone product could be achieved at around 24 
hours of conversion and the side product is unstable in time course.  
Figure 3.15: HPLC chromatogram of β-ionone conversions. Comparison of the 
conversion of β-ionone by E. coli strain carrying pETC4AA (green line) and pETC4 
(red green line)  
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Figure 3.16: HPLC chromatogram of β-ionone conversions. Comparison of the 
conversion of β-ionone by E. coli strain carrying pETC4AA after 22 hours (green line) 
and after 48 hours (red line)  
3.2. Cloning, expression and characterization of GeoA 
3.2.1. Computer-based identification of GeoA 
The putative terpene cyclase GeoA with locus_tag sce8552 (GenBank accession number 
YP_001619202) contains 329 amino acids. To study the phylogenetic relationship 
between GeoA with other proteins in the NCBI database, the amino acid sequence of 
GeoA was used as a query for the local BLAST search of the GenBank using a recent 
non-redundant protein database. The amino acid sequence was identified to belong to 
the isoprenoid biosynthesis enzymes, class 1. The 10 closest homologues of GeoA were 
identified and are listed in Table 3.2. GeoA has the higest sequence identity (34%) with 
a terpene synthase metal-binding domain-containing protein, which was identified as a 
monoterpene cyclase for biosynthesis of the off-flavor terpenoid alcohol-2-
methylisoborneol (2-MIB) of Roseiflexus castenholzii DSM 13941 (Komatsu et al. 
2008). It also shares 32% and 30% identity with putative pentalene synthase of So ce56 
and pentalene synthase of Streptomyces pristinaespiralis ATCC 5486, respectively. 
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Table 3.2: The closest homologues of the terpene cyclase 
Protein names Organism NCBI Reference 
Sequence 
% 
Identity 
Gaps 
% 
Terpene synthase metal-
binding domain-
containing protein 
Roseiflexus 
castenholzii
DSM 13941 
YP_001430766.1 34 3 
Terpene synthase metal-
binding domain-
containing protein 
Roseiflexus sp.
RS-1 
YP_001277817.1 33 2 
Terpene synthase, metal-
binding protein 
Rubrobacter 
xylanophilus
DSM 9941 
YP_643279.1 30 1 
Terpene synthase metal-
binding domain protein 
Chitinophaga 
pinensis DSM 
2588 
YP_003124367.1 29 2 
Terpene synthase metal-
binding domain-
containing protein 
Nostoc 
punctiforme 
PCC 73102 
YP_001867159.1 30 1 
Pentalenene synthase Sorangium 
cellulosum So 
ce56 
YP_001617016.1 32 1 
Pentalenene synthase Streptomyces 
pristinaespiralis
ATCC  5486 
ZP_06913376.1 30 4 
Terpene synthase metal-
binding domain protein 
Ktedonobacter 
racemifer DSM 
44963 
ZP_06965495.1 27 2 
Terpene synthase, metal-
binding 
Anabaena 
variabilis
ATCC 29413 
YP_322499.1 29 1 
Terpene synthase metal-
binding domain protein 
Chitinophaga 
pinensis DSM 
2588 
YP_003123612.1 27 5 
The genomic organization of genes coding for CYP264B1 and GeoA is similar to the 
sesquiterpene biosynthesis gene cluster of Streptomyces avermitilis (consisting of 
pentalenene synthase and CYP183A1) (Quaderer et al. 2006) and the sesquiterpene 
biosynthesis gene cluster of Streptomyces coelicolor A3 (consisting of epiisozizaene 
synthase and CYP170A1 (Zhao et al. 2008). Alignment of the terpene cyclase GeoA 
with the pentalene synthase and epiisozizaene synthase revealed that all contain two 
important domains characteristic for members of the terpene cyclase family: a 
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universally conserved aspartate-rich motif - DDXXD implicated in the binding of the 
pyrophosphate moiety of the substrate through chelation of the requisite divalent cation 
and a conserved triad of amino acid side chains - (D/N)DXX(S/T)XXXE - which plays 
an important role in Mg2+ binding (Rynkiewicz et al. 2001; Degenhardt et al. 2009) 
(Figure 3.17). Percentage identity between GeoA and these two sesquiterpene cyclases 
are 25% (with penetalene synthase) and 28% (with epiisozizaene synthase), 
respectively. 
Figure 3.17: Comparison of GeoA (sce8552) with pentalenene synthase (sav2998) 
from Streptomyces avermitilis and epiisozizaene synthase (Sco5222) from 
Streptomyces coelicolor A3. The amino acid sequences of these enzymes were aligned 
by ClustalW2. Conserved residues are shaded. DDXXD: Universally conserved 
aspartate-rich motif, implicated in the binding of the pyrophosphate moiety of the 
substrate through chelation of the requisite divalent cation; (D/N)DXX(S/T)XXXE: 
Conserved triad of amino acid side chains, plays an important role in Mg2+ binding 
3.2.2. Cloning of the GeoA gene   
The gene coding for GeoA was amplified from the genomic DNA of So ce56 using 
primer pairs as listed in Table 2.1. The reverse primer was designed to add a region 
sco5222  MHAFPHGTTATPTAIAVPPSLRLPVIEAAFPRQLHPYWPKLQETTRTWLLEKRLMPADKV 60 
sce8552  -------MSSDRTSVVVS-KRDAGGFEYPFAASCHPGREVTEQRTLAWVRRLRLVPDGRS 52 
sav2998  -------------------MPQDVDFHIPFPSRRSPDFERARADHLSWPRALGLIGTDAA 41 
                                  :. .*.    *     .    :*     *:  .   
sco5222  EEYADGLCYTDLMAGYYLGAPDEVLQAIADYSAWFFVWDDRHDRDIVHGRAGAWRRLRGL 120 
sce8552  LSRLKATNFSHLAAWLLPSASTQTLQLASDFTAVLFLLDDAYDEGQLSTDPESVEWLNEK 112 
sav2998  AERHSRGGYADLAARFYPSATGADLDLGVDLMSWFFLFDDLFD-GPRGEDPQETRKLTDA 100 
          .  .   ::.* *    .*.   *:   *  : :*: ** .* .     .   . *    
sco5222  LHTALDSPGDHLHHEDTLVAGFADSVRRLYAFLPATWNARFARHFHTVIEAYDREFHNRT 180 
sce8552  YLGELFG-YTEADMSDPLTRGMLDVRERIRRSHPHFFLNRWLSHFQYYYEANLWEANNRK 171 
sav2998  VAAALDG--PLPTSAPPIAHGFADVWRRTCQGMSPAWRARSARHWRNYFSGYVDEAVSRH 158 
             * .         .:. *: *  .*     .  :  *   *::   ..   *  .*  
sco5222  R-GIVPGVEEYLELRRLTFAHWIWTDLLEPSSGCELPDAVRKHPAYRRAALLSQEFAAWY 239 
sce8552  Q-MRVPHLEEYLMMRRYSGAVYTYCDLLELLLERPLPLEVVQHPLIQTVRDICNDILCWT 230 
sav2998  LNTPYDSAGHYLAMRRQTIGVQPTVDLAERSCHCEVPQRVFDSAVLFAMLQIATDTNLIL 218 
                  .** :** : .     ** *      :*  * . .       :. :      
sco5222  NDLCSLPKEIAGDEVHNLGISLITHHSLTLEEAIGEVRRRVEECITEFLAVERDALRFAD 299 
sce8552  NDYFSLGKELTNGETHNLIVVLRNECVSTLEEAIDRLKDMHDRRVAEYQGVKEKVL---A 287 
sav2998  NDIASLEKEEARGELNNMVFILMREHGWTRGRSIAHMQDGVRTRLEQFLLLEACLP---K 275 
         **  ** ** : .* :*: . *  .   *  .:* .::      : ::  ::         
sco5222  ELADGTVRGKELSGAVRANVGNMRNWFSSVYWFHHESGRYM-VDSWDDRSTPPYVNNEAA 358 
sce8552  LWADDEIR-LYLDAVEAMIAGNQR--------WALEAGRYSGLESLIVRAG--------- 329 
sav2998  VYDTFELTAQERESAEKYRMDGVRSVIRGSYDWHRSSGRYAADYAIAASYQG-YLEELGS 334 
               :     ...     .. *        :  .:***    :                
sco5222  GEK 361 
sce8552  --- 
sav2998  TL- 336
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encoding a His6-tag to the gene. PCR amplification using phusion polymerase as 
described in the section 2.2.1.1, yielded a fragment of the expected size of 1008 bp 
(Figure 3.18). This fragment was then inserted into expression vector pET17b between 
NdeI and HindIII sites for heterologous protein expression. 
Figure 3.18: Agarose gel electrophoresis of terpene cyclase PCR product (using 1% 
agarose gel). Lane 1 - Marker Smart Ladder (Eurogentec); Lane 2 - PCR product 
3.2.3. Protein expression and purification 
GeoA was overproduced as His-tagged fusion proteins in E. coli BL21(DE3). To 
monitor the expression level, different temperatures (from 25°C to 37°C) were 
investigated. The expression levels were estimated by SDS-PAGE for the crude extract. 
However, at first no expression was observed (data not shown). To optimize the protein 
expression, conditions similar to those used for the CYP264B1 expression were applied 
for GeoA. Thus, GeoA was co-expressed with the chaperones GroES/GroEL at 28°C 
and, indeed, a new band at the size expected for GeoA was observed very clearly 
(Figure 3.19). After affinity (IMAC) and size exclusion chromatography, the yield of 
the purified protein attained 16.3 mg/l culture. The purity of GeoA was estimated by 
SDS-PAGE and the protein’s molecular weight was in good agreement with the 
predicted value of 38.92 kDa (Figure 3.19). 
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Figure 3.19: SDS-PAGE represents the expression and purification of terpene 
cyclase GeoA. Lane 1 and 2 - cell lysate after 48 hours of co-expression with 
chaperone; Lane 3 - cell lysate before induction; Lane 4 - protein marker (pEQLab); 
Lane 5 - purified terpene cyclase   
3.2.4. Substrate identification 
Terpene cyclases are the primary enzymes responsible for catalyzing the formation of 
monoterpenes (C10), sesquiterpenes (C15) or diterpenes (C20) from the universal 
prenyl pyrophosphate precursors GPP, FPP or GGPP, respectively (Tholl 2006). 
Therefore, these three substrates were tested in in vitro conversion. After incubation 
with GeoA in a reaction mixture containing Mg2+, compounds were extracted with n-
hexan and analysed by GCMS as described in the section 2.2.11.4. A single product 
peak was detected for the reaction mixtures containing FPP (Figure 3.20) and GGPP 
(Figure 3.21) at retention times of 22 min and 32 min, respectively. In case of GPP, 
there was no product peak observed (data not shown). It is noteworthy, that the 
substrates were not observed in the chromatogram because they are hydrophilic 
compounds and thus do not enter the n-hexan phase. In the reaction without adding 
Mg2+, no product was found (data not shown). This indicates that Mg2+ plays an 
important role for the activity of the terpene cyclase GeoA. 
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Figure 3.20: Gas chromatogram of FPP conversion by terpene cyclase GeoA 
Figure 3.21: Gas chromatogram of GGPP conversion by terpene cyclase GeoA 
3.2.5. Product identification 
Identification of the products of FPP and GGPP conversions was attempted based on 
comparison of the mass spectra to the mass spectra library of NIST 2.0 (National 
Institute of Standards and Technology). The product of FPP is a sesquiterpene with 89% 
similarity to valencene - a sesquiterpene that is an aroma component of citrus fruit and 
citrus-derived odorants (Figure 3.22). The product of GGPP is a diterpene with 80% 
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similarity to neocembrene A - a major component of the trail-following pheromone in 
the genus Prorhinotermes (Sillam-Dusses et al. 2005) (Figure 3.23).   
   
Figure 3.22: Mass pectra of terpene cyclase product from FPP 
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Figure 3.23: Mass pectra of terpene cyclase product from GGPP 
  
3.3. Identification of products of the TPSgc encoding enzymes 
3.3.1. Product formation in the in vitro conversions 
To study the genuine product formed by the enzymes of the TPSgc, CYP264B1 and 
GeoA were incubated in a reaction mixture containing substrate (FPP or GGPP) and all 
necessary components as described in the section 2.2.7.3. After incubating at 30°C for 1 
hour in a thermomixer, reactions were stopped by adding chloroform, extracted twice 
and dried in a vacuum-drier. The samples were dissolved in 100 µl of ethyl acetate and 
spotted on TLC using n-hexan/ethyl acetate (3/2) as developing solvent. After staining 
with vanilline, the results showed that CYP264B1 was able to convert the sesquiterpene 
product of GeoA into one product, which has a Rf of 0.63 (Figure 3.24).  
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Figure 3.24: TLC chromatogram of FPP conversion by the TPSgc encoding 
enzymes. Lane 1 - FPP conversion; Lane 2 - negative control with boiled CYP264B1; 
Lane 3 - negative control with boiled GeoA; Lane 4 - negative control without 
substrate; Lane 5 - negative control without NADPH. Arrow represents the product of 
the TPSgc encoding enzymes 
Similarly, CYP264B1 was able to convert the diterpene product of GeoA into one 
product, which has a Rf of 0.95 (n-hexan/ethyl acetate: 3/7) (Figure 3.25). In the 
negative controls (with boiled CYP254B1 or with boiled GeoA or without substrate or 
without NADPH) no products were detected. These results suggest that GeoA produced 
a sesquiterpene and a diterpene from FPP and GGPP, respectively, which can both serve 
as substrates for CYP264B1. The postulated route of terpene biosynthesis from prenyl 
pyrophosphate precursors by the TPSgc encoding enzymes CYP264B1-GeoA is 
illustrated in Figure 3.26. 
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Figure 3.25: TLC chromatogram of GGPP conversion by the TPSgc encoding 
enzymes. Lane 1 - negative control without NADPH; Lane 2 - GGPP conversion; Lane 
3 - negative control with boiled CYP264B1; Lane 4 - negative control with boiled 
GeoA. Arrow represents the product of the TPSgc encoding enzymes 
From these results, the routes of the biosynthesis of sesquiterpene X from FPP and 
diterpene Y from GGPP by the TPSgc encoding enzymes were postulated as shown in 
Figure 3.26. 
Figure 3.26: Postulated routes of terpene biosythesis by the TPSgc encoding 
enzymes from FPP and GGPP 
FPP Sesquiterpene X 
(similar to valencene)
Sesquiterpenoid X-OH
GeoA CYP264B1
GGPP Diterpen Y 
(similar to neocembrene A)
Diterpeneoid Y-OH
GeoA CYP264B1
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3.3.2. Comparison of sesquiterpene product X with valencene 
As mentioned above, GeoA converted FPP into a sesquiterpene X, which has 89% 
similarity to valenecene. GC-MS showed that valencene and this sesquiterpene have a 
similar retention time of 20 min at the same conditions (data not shown); also the mass 
spectra of these two compounds are similar but are not identical (Figure 3.27). 
Figure 3.27: Mass spectra of valencene and the sesquiterpene product of terpene 
cyclase 
In order to confirm whether the sesquiterpene X is valencene or not, we compared the 
conversion of sesquiterpene X with the conversion of valencene by CYP264B1. 
Reactions were performed as described in the section 2.2.7.3. Analysis with TLC 
showed that CYP264B1 converted valencene into at least four different products 
whereas it converted the sesquiterpene X into one specific product (Figure 3.28). 
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Therefore, it must be concluded that the sesquiterpene product of GeoA is not 
valencene, but a new compound not present in the database of National Institute of 
Standards and Technology (NIST).  
Figure 3.28: TLC chromatogram. Sesquiterpene product conversion by CYP264B1 
(a) Lane 1 - FPP conversion by terpene cyclase and CYP264B1; Lane 2 - negative 
control without NADPH. Valencene conversion by CYP264B1 (b) Lane 1 - negative 
control without NADPH; Lane 2 - valencene conversion. The developing solvent 
containing n-hexan/ethylacetat (4/1) was used. Arrow represents the product of the 
TPSgc encoding enzymes 
3.3.3. Conversion of the products of GeoA by different CYPs of So ce56 
The result above showed that CYP264B1 was able to convert both the sesquiterpene X 
and the diterpene product Y of terpene cyclase. In order to determine whether the 
products of the terpene cyclase sce8552 are also converted by other CYPs of the So 
ce56 or if they are exclusively used by CYP264B1 as substrates, five additional So ce56 
cytochrome P450s (CYP264A1, CYP109C2, CYP109C1, CYP109D1, CYP260A1) 
were selected for in vitro conversion assays based on their close phylogenetic 
relationship to CYP264B1 (these CYPs were kindly provided by Dr. Yogan Khatri). 
These enzymes were known to be supported by Adx and AdR (Khatri PhD Thesis 
2009). The reconstituted systems of these CYPs were incubated with FPP or GGPP 
together with GeoA as described in the section 2.2.7.3. Interestingly, 4 out of 5 CYPs 
(CYP264A1, CYP109C2, CYP109C1, CYP109D1) were not able to convert the 
products of GeoA (Figure 3.29 and Figure 3.30). Only CYP260A1 was able to convert 
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the products of GeoA but less specific than CYP264B1, since at least 2 products were 
observed, neither of which being identical to the product of CYP264B1 (Figure 3.29 
and Figure 3.30). This result demonstrates that the sesquitepenoid X-OH and 
diterpenoid Y-OH are the product of terpene cyclase and only one cytochrome P450 of 
So ce56 – CYP264B1. 
Figure 3.29: TLC chromatogram of the conversion of FPP by GeoA and different 
cytochromes P450 of So ce56.  Lane 1 - CYP264B1; Lane 2 - CYP264A1; Lane 3 - 
CYP109C2; Lane 4 - CYP109C1; Lane 5 - CYP109D1, Lane 6 - CYP260A1. The 
developing solvent containing n-hexan/ethylacetat (5/2) was used. Arrow represents the 
product of the TPSgc encoding enzymes 
Figure 3.30: TLC chromatogram of the conversion of GGPP by GeoA and 
different cytochrome P450s of So ce56.  Lane 1 - CYP264B1; Lane 2 - CYP264A1; 
Lane 3 - CYP109C2; Lane 4 - CYP109C1; Lane 5 - CYP109D1; Lane 6 - CYP260A1. 
The developing solvent containing n-hexan/ethylacetat (3/2) was used. Arrow represents 
the product of the TPSgc encoding enzymes 
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 3.4. Investigation of terpenoid production in engineered E. coli
As described above, the terpene cyclase GeoA converted FPP and GGPP into a 
sesquiterpene X and a diterpene Y, respectively. The mass spectra of these products did 
not match with any compound included yet in the National Institute of Standards and 
Technology (NIST) database. Therefore, they are likely to be novel metabolites and, it 
is necessary to identify them by NMR method. To produce a sufficient amount of these 
compunds (sesquiterpene X and X-OH and diterpene Y and Y-OH) for analysis, the in 
vitro convesion requires 4 purified proteins (terpene cyclase, CYP264B1, Adx and 
AdR) and the expensive cofactor NADPH as well as the very expensive precusors FPP 
and GGPP (≈ 2600 € /10 mg). Thus, an in vitro conversion would not be economical, 
even if the terpenoids produced should prove to be of e.g. pharmaceutical interest. Due 
to such considerations, metabolically engineered microorganisms are nowadays widely 
used as host for the heterologous production of isoprenoid compounds (Martin 2003).  
In this work, we used E. coli for this purpose, because these bacteria offer advantages in 
terms of higher growth rate and easy genetic manipulation. Since E. coli produce a very 
limited amount of FPP through their native MEP pathway, a heterologous isopropenoid 
(MEV pathway) was introduced into this host to enhance isoprenoid flux for FPP 
production (Harada et al. 2009). We introduced the genes encoding the mevalonate-
dependent isoprenoid pathway originating from Streptomyces sp. strain CL190 (vector 
pAC-Mev or pAC-Mv) and expressed them in E. coli (these vector were kindly 
provided by Prof Norihiko Misawa, Research Institute for Bioresources and 
Biotechnology, Ishikawa Prefectural University, Japan). 
3.4.1. E. coli strain and culture medium 
Since protein expression of both CYP264B1 and GeoA require the co-expression with 
the chaperones GroEL and GroES, production of terpene compounds in this strains 
become difficult when introducing the mevalonate vector as a third vector. Therefore, 
C43(DE3), a mutant of the previously used of E. coli BL21(DE3), was tested for the 
expression of CYP264B1 and GeoA. This strain is often used to overcome the toxicity 
when recombinant proteins are over-expressed using the bacteriophage T7 RNA 
polymerase expression system (Dumon-Seignovert L et al. 2004). In addition, LB and 
TB culture media were also tested because the carbon source is known as a factor, 
which could have an influence on the protein expression level (Lee et al. 2004. The 
protein expression from crude extract was analyzed by SDS-PAGE (Figure 3.31). 
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Figure 3.31: SDS-PAGE of the expression of GeoA in E. coli C43(DE3). Lane 1 - 
cell lysate at 0 h of expression; Lane 2 - cell lysate after 20 h of expression in LB 
medium; Lane 3 - protein marker (pEQLab); Lane 4 - cell lysate after 44 h of expression 
in TB medium; Lane 5 - cell lysate after 20 h of expression in TB medium 
As shown in Figure 3.31, bands corresponding to GeoA were observed 20 hours after 
induction in TB medium. In contrast, no expression was observed when LB medium 
was used. The concentration of CYP264B1 determined by the CO difference spectra 
method was 513 nmol per litre culture. For this reason, the C43(DE3) strain and TB 
medium were used for the production of terpene compounds. 
3.4.2. Terpene production with GeoA 
To produce the products of GeoA, E. coli C43(DE3) carrying plasmids pETG and pAC-
Mev (or pAC-Mv) were cultured in 30 ml TB medium as described in section 3.2.10.1. 
Since the products of terpene cyclase are often volatile, the culture was overlaid with 10 
ml decane to capture the released compounds. After 48 hours of incubation at 27οC, 100 
µl of the overlay-decane phase was sampled for GCMS analysis. The result showed that 
there was a sesquiterpene present in the decane phase (data not shown). 
The mass spectrum of the detected sesquiterpene was compared to that of sesquitepene 
X found in the in vitro conversion of FPP. The relative ion abundances for the 
sesquiterpene  produced in vivo correlated with the values of sesquiterpene X for all ion 
fragments: 41, 55, 77, 91, 107, 120, 133, 147, 161, 175, 189, 204 m/z ions (Figure 
3.32). In contrast, a control extract prepared from E. coli C43(DE3) transformed with 
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only pAC-Mev (or pAC-Mv) did not give any products, confirming the fact that E. coli
does not produce any monoterpene, sesquiterpene or diterpene compounds (Connolly 
and Winkler 1989; Apfel et al. 1999). The results obtained here indicated that the 
sesquiterpene X product of GeoA was produced in the engineered E. coli strain. 
Figure 3.32: GC-MS of the detected sesquiterpene in decane phase overlaid the 
cultrure 
When mevalonate (0.5 mg/ml) was supplied to the medium, sesquiterpene X production 
was improved 2.5 fold (Figure 3.33). Since E. coli is not able to utilize mevalonate 
without the introduction of the foreign mevalonate pathway gene (Yoon et al. 2007), 
this result indicates that the introduced mevanolate pathway was active in this strain. 
Sesquiterpene X yield was estimated using valencene as external standard in GCMS. 
Recombinant E. coli harboring the complete mevalonate pathway (pAC-Mev) and 
pETG produced 0.5 mg of sesquiterpene X per 50 mL E. coli culture after 48 h, a yield 
1.2-fold higher than that produced by the strain haboring the “bottom” pathway (pAC-
Mv) and pETG (Figure 3.33). 
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Figure 3.33: Sesquiterpene X production by E. coli C43(DE3) haboring different 
plasmids. “+M” or “–M” indicates “with addition of” or “without addition of” D-
mevalonolactone, respectively; nd - not detected 
3.4.3. Terpene production with CYP264B1 and GeoA 
In order to produce product of the TPSgc encoding enzymes, E. coli C43(DE3) carrying 
plasmids pETC4AAG and pAC-Mev or plasmids pAC-MvC4 and pETGAA were 
cultured in TB medium; at the time of induction with IPTG, 0.5 mg/ml mevalonate (M) 
was added to the culture as described above. In this setting, besides the terpene cyclase 
GeoA and the enzymes of the mevalonate pathway, also CYP264B1 and its redox 
partners were expressed. To analyze the in vivo conversion, aliquots of 0.5 ml culture 
were centrifuged to remove the cells. Supernatant was extracted with chloroform and 
analyzed by TLC. The result showed that no product was detected in this case (data not 
shown). It was disscussed by Yu and coworkers (Yu et al. 2011) in their work that the 
low yield of hydroxylated sesquiterpene in E. coli might be due to the inefficient 
transport of hydrophobic sesquiterpene from the cytosol to the hydroxylation sites. 
Therefore, we used hydroxypropyl--cyclodextrin (CD) with the hope that it will be 
able to capture the released volatile sesquiterpene. This compound is known as an 
enhancer of the permeation of poorly soluble compounds through biological membranes 
(Másson et al. 1999). CD was added into the culture to get a final concentration of 
1.13% (w/v) at the time of induction. After 48 hours, the terpenoid production was 
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analyzed by TLC. Interestingly, when CD was added to the culture, a product was 
detected which has an retention factor (Rf of 0.33) identical to the one of the product of 
FPP in vitro conversion by the TPSgc encoding enzymes CYP264B1-GeoA (Figure 
3.34).  
Figure 3.34: TLC chromatogram of FPP conversion. The in vitro conversion of FPP 
by the TPSgc encoding enzymes (Lane 2) and terpene production of E. coli C43(DE3) 
haboring pAC-MvC4/pETGAA (Lane 3); Lane 1 - negative control of in vitro FPP 
conversion without NADPH. The developing solvent containing n-hexan/ethylacetat 
(5/2) was used. Arrow represents the putative product of CYP264B1 and GeoA 
produced by E. coli C43(DE3) 
In order to confirm whether this product was formed by the TPSgc encoding enzymes or 
not, different vector combinations were transformed and expressed in E. coli C43(DE3). 
The effects of presence or absence of hydroxypropyl--cyclodextrin and D-
mevalonolactone were also tested. As shown in Figure 3.35, the product with a Rf 0.33 
was not present in the cultures harboring pETC4AAG/pAC-Mev and pAC-
MvC4/pETGAA when neither hydroxypropyl--cyclodextrin nor D-mevalonolactone 
were added. In contrast, this product was observed in the cultures supplemented with 
hydroxypropyl--cyclodextrin, irrespective of the addition of D-mevalonolactone. 
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Figure 3.35: TLC chromatogram analysis of terpene production of E. coli
C43(DE3) haboring different vector. (a) Lane 1, 2, 3 and 4 - pETC4AAG/ pAC-Mev; 
Lane 5 – pAC-MvC4/pETGAA. (b) Lane 1, 2, 3 and 4 – pAC-MvC4/pETGAA; Lane 5 
- pETC4AAG/pAC-Mev. (+) - addtion of; (-) - without addtion of; M – D-
mevalonolactone; CD - hydroxypropyl--cyclodextrin. The developing solvent 
containing n-hexan/ethylacetat (5/2) was used. Arrow indicated the retention factor of 
the putative product of CYP264B1 and GeoA produced by E. coli C43(DE3) 
In addition, when pETC4AAG was transformed alone and the heterologous mevalonate 
pathway was not introduced in the host, the product was also detected in the culture 
supplemented both M and CD (data not shown). However, the product was not observed 
in the culture harboring pAC-MvC4 even when both M and DC were supplemented 
(Figure 3.36).  
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Figure 3.36: TLC chromatogram analysis of terpene production of E. coli
C43(DE3) haboring different vector. Lane 1, 2, 3 - pAC-MvC4/pETGAA; Lane 4 - 
pAC-MvC4. The developing solvent containing n-hexan/ethylacetat (7/2) was used. 
Arrow represent the putative product of CYP264B1 and GeoA produced by E. coli
C43(DE3) 
Taken together, it can be stated that the mevalonate engineered E. coli C43(DE3) was 
able to produce sesquiterpene X when the gene coding for the terpene cyclase GeoA 
was introduced into this host. For production of the hydroxylated product X-OH of the 
TPSgc encoding enzymes, hydroxypropyl--cyclodextrin might be used to overcome 
the loss of the volatile sesquiterpene X from the culture, so that the yield of the 
hydroxylated product might be improved. However, to comfirm the hydroxylated 
product, mass spectra analysis for this expriment is necessary. 
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4. DISCUSSION 
4.1. Characterization of CYP264B1 
P450s are versatile biocatalysts and their regio- and stereo-selective activities are 
particularly attractive for biotechnological processes exploiting new substances of 
industrial value (Bernhardt 2006). In recent years, genome sequencing projects 
disclosed information on many new P450 genes which provides a valuable basis for 
potential industrial applications. In 2007, the whole genome sequence of the 
myxobacterium Sorangium cellulosum So ce56 was published, revealing 21 novel 
putative P450s. The strain So ce56 possesses the largest genome discovered in bacteria 
to date and produces several bioactive compounds including chivosazol, etnangien, and 
myxochelin (Schneiker et al. 2007; Wenzel and Muller 2009). Characterization of 
P450s of this strain therefore promises an interesting contribution for P450-centered 
biotechnology.  
This study describes the expression and characterization of CYP264B1, one of 21 P450s 
of So ce56. In a previous work in our laboratory, the gene encoding CYP264B1 was 
cloned into the E. coli expression vector pCWori+ and expressed in E. coli BL21, but 
the expression level was very low (only 4 nmol/L culture). In order to improve the 
expression, the gene was cloned into pET17b and expressed in E. coli BL21(DE3), but 
the yield was still not improved (Khatri PhD thesis 2009). Since the high GC content of 
target genes is biased against E. coli codon usage (Redwan 2006), it could influence the 
protein expression of So ce56’s P450s in heterologous hosts such as E. coli. Several 
reports have shown the improvement of protein expression from high GC content genes 
in E. coli by codon optimization (Panahi et al. 2004; Srivastava 2005). However, it was 
shown that among the 21 So ce56 P450s, several were expressed at high levels (more 
than 1000 nmol/L culture) in E. coli without changing the nucleotide sequence, 
including CYP109C1, CYP109C2 and CYP266A1. In addition, it was also reported that 
the elimination of rare codons does not increase the expression of the Rv3297 gene in E. 
coli (Guo et al. 2009). The reason for the difference in expression levels of So ce56 
P450 genes remains elusive since a comparison of the occurrence of E. coli rare codons 
with these genes disclosed no correlation of the frequency of rare codons and the 
expression level observed in E. coli (Khatri PhD thesis 2009). It seems that other 
reasons, rather than codon bias caused by high GC content, are responsible for the low 
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protein expression in heterologous host E. coli. In their study, Han et al. (Han et al.
2010) pointed out that the high GC content is likely responsible for many stable stem 
structures on the mRNA of human peptide deformylase, which influence the 
transcription or translation of the N-terminal-tagged gene and inhibits the protein 
expression. The high GC content present on the translation initiation region is especially 
showing this effect (Guo et al. 2009; Gu et al. 2010). According to Francis and Page 
(Francis and Page 2010), protein expression in E. coli requires four elements: (1) the 
protein of interest, (2) a bacterial expression vector, (3) an expression cell line, and (4) 
the equipment/materials for bacterial cell culture. Thus, if genes coding of all 21 So 
ce56’s P450s were cloned into the same pCWori+ vector and expressed under the same 
conditions, but the expression levels of different protein were not the same, it is because 
of the intrinsic properties of each protein itself (e.g. hydrophobic residues, complexity 
regions or disulfide bonds). When these P450s are expressed in heterologous hosts, 
where the internal microenvironment differs from that of So ce56 (e.g. pH, osmolarity), 
the interaction of these proteins with new environments and mechanisms for folding are 
different, leading to differences in the expression level. Therefore, in this context, 
simple elements, such as expression temperature, should be first investigated. Lowering 
the expression temperature is often suggested, since at lower temperatures cell processes 
slow down leading to reduced rates of transcription, translation, and cell division (Chou 
2007), while also leading to reduced aggregation and improved solubility of 
recombinantly expressed proteins (Shirano and Shibata 1990; Sahdev et al. 2008; 
Volonte et al. 2008). In addition, this also results in a reduction in the degradation of 
proteolytically sensitive proteins since most proteases are less active at lower 
temperatures (Francis and Page 2010; Hunke and Betton, 2003; Pinsach et al. 2008). 
Moreover, if high GC content is the reason as discussed above, lowering the 
temperature also can help because prokaryotes living in colder environments tend to 
have comparatively less stable mRNA secondary structure at the translation-initiation 
region (Gu et al. 2010). In our work, when lowing the expression temperature to 20οC, 
the yield of CYP264B1 was improved from 4 nmol to 257 nmol/L culture. However, 
this yield is still rather low and scarcely sufficient to obtain enough protein for further 
studies. The molecular chaperone GroEL of E. coli is known to be essential for the 
folding of many proteins in vivo and in vitro (Ellis 1991; Landry and Gierasch 1994); 
also the cochaperonin GroES, a member of the heptameric cpn10 family, is an essential 
additional component for the GroEL-mediated folding of some proteins in vitro
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(Chandrasekhar et al. 1986). Therefore, the pET17b vector carrying the CYP264B1 
gene was co-transformed with the plasmid pGro12 carrying the molecular chaperones 
GroES and GroEL into E. coli BL21(DE3). As expected, the protein expression level 
improved to 820 nmol/L culture which was sufficient for the characterization of 
CYP264B1. Spectrophotometric characterization of the carbon monoxide bound form 
of CYP264B1 gave a typical peak maximum at 450 nm and a dominating shoulder at 
420 nm.  
Since most P450s perform their chemical reactions after receiving reduction equivalents 
from NADPH or NADH through autologous or heterologous electron transfer partners 
(Hannemann et al. 2007), we sought to identify redox partners for CYP264B1. The 
genome of S. cellulosum So ce56 contains 8 ferredoxins (Fdx) and 2 ferredoxin 
reductases (FdR) genes, but none of them is located in the vicinity of a P450 gene 
(Ewen et al. 2009). Therefore, the prediction of natural redox partners for CYP264B1 
was not possible using solely genomic information. Thus, the available myxobacterial 
redox proteins as well as the heterologous adrenodoxin (Adx4-108) and adrenodoxin 
reductase (AdR) form bovine adrenals were tested as potential redox partners for 
CYP264B1 based on the CO diference spectra method (Omura and Sato 1964). The 
result showed that the electron transfer capability of the heterologous redox proteins 
Adx-AdR to CYP264B1 was much better than the one of Fdx2-FdRB and Fdx8-FdRB 
(see section 3.1.3). This observation is in accordance with results obtained with 
CYP109D1, CYP264A1, and CYP266A1 (Khatri et al. 2010) and CYP260A1 (Ewen et 
al. 2009) from this bacterium, which also showed higher activity with Adx and AdR 
compared with the redox pairs Fdx2/FdRB or Fdx8/FdRB. Therefore, Adx and AdR 
were selected as redox partners of CYP264B1. 
In the genome of So ce56, the CYP264B1 gene is clustered with a putative terpene 
cyclase gene with only 63 base pairs separating the two genes. Thus it seems likely that 
CYP264B1 is involved in terpene biosynthesis. While we tried to identify and produce 
the natural substrate of CYP264B1 (see below), we also decided to perform a screening 
with diverse terpenoid compounds and substances with similar structures as potential 
substrates for CYP264B1. In this work, seven sesquiterpenoids (nootkatone, valencene, 
α-longipinene, clovene, humulene, isolongifolene-9-one and copaene), two 
norisoprenoids (α-ionone and β-ionone) as well as ten compounds belonging to other 
groups (monoterpene, diterpene acid, steroid, keton and aroma related compounds) were 
tested. Among 22 investigated compounds, 14 compounds induced a type I spectrum of 
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CYP264B1 (see section 3.1.4) and were therefore considered as potential substrates. An 
in vitro conversion by CYP264B1 using Adx and AdR as redox partners was carried out 
for these 14 potential substrates. Interestingly, among them 8 compounds belonging to 
the sesquiterpenes and norisoprenoids were found to be converted by CYP264B1 (see 
section 3.1.6). Among the identified substrates, we focused on nootkatone and α-/β-
ionone because of the high selectivity of the CYP264B1-catalyzed hydroxylation of 
these substances. Thus the products of α-/ β-ionone and nootkatone conversions were 
further characterized.  
Ionones and their derivatives are important constituents of essential oils, which are 
found in flowers, fruits, and leaves of many plants (Mikami 1981; Ohloff 1978). Since 
ionones are known as interesting substances for fragrance and flavor industry (Brenna 
2002), over the last decades the regio-selective and/or enantio-selective conversion of 
ionones has been investigated with growing interest. However, it has been shown that 
the bio-transformations of α-/β-ionone by using microorganisms (Mikami et al. 1981; 
Larroche et al. 1995; Lutz-Wahl et al. 1998; Urlacher et al. 2006) or even selected 
P450s (Celik et al. 2005; Girhard 2010) often resulted in mixtures of hydroxyl- and/or 
oxo-derivatives, which is not desirable for industrial application. In contrast with 
CYP264B1, we observed a highly selective hydroxylation of α- and β-ionone resulting 
in the respective 3-OH products; these products might be important and might find an 
industrial application as intermediates for the synthesis of carotenoids, e.g. of 
astaxanthin and zeaxanthin (Loeber 1971), or deoxyabscisic acid, a synthetic analogue 
of the phytohormone abscisic acid (Larroche et al. 1995). Because of the potential 
industrial application of 3-OH ionone derivatives, several biotransformation studies 
were described in the literature, including the screening of 215 Streptomyces strains for 
the regio- and stereo-selective hydroxylation of α-/β-ionone. However, none of them 
converted β-ionone into 3-hydroxy-β-ionone (Lutz-Wahl et al. 1998). Even though we 
have demonstrated recently that CYP109D1 was able to convert β-ionone 
regioselectively, the 3-OH product of β-ionone has not been obtained so far (Khatri et 
al. 2010). Instead, 4-hydroxy-β-ionone was found. Thus, it seems that C-3 of α-ionone 
and C-4 of β-ionone were the most frequent positions of biooxidation systems for the 
hydroxylations. In terms of stereochemistry, C-3 of α-ionone is often a favored position 
for hydroxylation because of the presence of two methyl groups at C-1 position that 
direct any oxidative attack toward C-3. Likewise, the C-4 position of β-ionone is also 
4. Discussion 77
favored because of the electronic activation of the allylic hydrogens by the double bond 
of the cyclohexane ring, which governs the regio-selective hydroxylation at this 
position. Nevertheless, in a recent publication, the conversion of β-ionone by 
CYP101B1 and CYP101C1 from Novosphingobium aromaticivorans was reported to 
result in a 3-hydroxylated product albeit this product was found in a mixture with 4-
hydroxy-β-ionone (Bell et al. 2010). In contrast to the Novosphingobium CYPs, 
CYP264B1 from S. cellulosum So ce56 is able to hydroxylate both α- and β-ionone in a 
highly regio-selective manner at C-3 position, giving 3-hydroxy-α-ionone and 3-
hydroxy-β-ionone, respectively. This finding of a regio-selective hydroxylation of α- 
and β-ionone by CYP264B1 at the C-3 position implies a very rigid orientation of the 
trimethylcyclohexane ring within the enzyme’s active site. To gain more insight into the 
structural basis for the selectivity of hydroxylation, both, α- and β-ionone, were docked 
into the active site of CYP264B1. As shown in Fig. 3.13 (section 3.1.8), the optimal 
orientation allowing a suitable arrangement for hydroxylation was only observed for the 
C-3 position. The computational data thus confirmed our experimental observation that 
CYP264B1 hydroxylates both α- and β-ionone at the same position, C-3. 
Nootkatone, the other substrate of choice, is also an interesting compound for detailed 
investigations because of its flavoring properties (Fraatz et al. 2009), pharmacological 
importance (Tassaneeyakul et al. 2000; Murase et al. 2010) and insecticidal activity 
(Miyazawa et al. 2000; Zhu et al. 2001; Panella et al. 2005). In this study, the 
hydroxylation position of nootkatone was identified to be at C-13. This makes the 
nootkatone product of CYP264B1 pharmaceutically highly interesting, sine it was 
shown previously that 13-hydroxy-nootkatone displays an increased antiproliferative 
activity towards a cancer cell line compared to other hydroxylated products of 
nootkatone (Gliszczynska et al. 2011). Moreover, the presence of 13-hydroxy-
nootkatone in the secrete of diseased wood of Chamaecyparis lawsoniana was 
suggested to play a role of this compound in controlling fungal infection (Takashi 
2007). It is of special interest that although many biotransformations of nootkatone were 
investigated, a hydroxylation at C-13 was never observed so far (Furusawa et al. 2005; 
Borges 2009; Hegazy et al. 2006). This indicates that the selective hydroxylation of 
nootkatone at C-13 position seems to be difficult to obtain via biooxidation processes. 
Thus, CYP264B1 provides a novel and highly interesting system for the production of 
this attractive metabolite of nootkatone. 
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In summary, CYP264B1, a novel P450 from the myxobacterium So ce56, was 
successfully expressed, purified and characterized. In addition to two endogenous redox 
chains (FdRB-Fdx2 and FdRB-Fdx8) also the more efficient heterologous redox 
proteins constituting the electron transfer chain Adx-AdR were identified as interaction 
partners. Among the screened potential substrates, norisoprenoids (α- and β-ionone) 
and sesquiterpenes were converted by CYP264B1. Since norisoprenoids can be 
considered as degraded sesquiterpenoids (Gomes-Carneiro et al. 2006), CYP264B1 is 
identified as a novel sesquiterpene hydroxylase. 
4.2. E. coli whole-cell biocatalyst for sesquiterpene conversion 
Sesquiterpenes are the most diverse group of terpenoid compounds and common 
constituents of essential oils in plants (Fraga 2006; Edris 2007). Herbs and higher plants 
containing sesquiterpenoids have been exploited in traditional medicine since ancient 
times (Sauter 2011; Chu 2011; Galani 2010). The derivatives of the sesquiterpenes often 
possess desirable fragrances and flavoring or pharmaceutical properties (Fraga 2006). In 
addition, they can be used as starting materials to synthesize high-value compounds like 
amorpha-4,11-diene, the precursor for the potent antimalarial drug artemisinin, and 
germacrone, the starting compound in the synthesis of the anticancer drug β-elemene 
(Chang 2000; Barrero 2011). Since the great majority of terpenoids are biologically 
active, many of them have been modified to create novel substances with desired 
properties (Azerad 2000). The hydroxylation of sesquiterpenes, an essential step in the 
production of flavour molecules in flavour and fragrance industry, was often used to 
enhance their sensory properties (Faber 2000, Cankar et al. 2011). For this purpose, bio-
oxidation systems are more advantageous in comparison to chemical synthesis by mean 
of cost and time efficiency, as well as environmentally friendly habit. Furthermore, 
using oxidase enzymes such as cytochromes P450, the ability of introducing an atomic 
oxygen into allylic positions, double bonds or even into non-activated C–H bonds, 
which is difficult for chemical synthesis, can be achieved (Bernhardt 2006, Urlacher et 
al. 2004). As described above, CYP264B1 was identified as a novel sesquiterpene 
hydroxylase, which is able to convert diverse sesquiterpene substrates. According to the 
best of our knowledge, until now, besides CYP264B1, only one cytochrome P450, 
named premnaspirodiene oxygenase, from the plant Hyoscyamus muticus has been 
reported to be capable of hydroxylating diverse sesquiterpene substrates (Takahashi et 
al. 2007). However, the utilization of P450s from bacteria is more desirable than that 
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from plants and animals because they are not membrane associated and normally exhibit 
a higher stability and activity (Urlacher et al. 2004). Moreover, CYP264B1 displays 
interesting characteristics towards the hydroxylation of its substrates. It is able to 
hydroxylate these compounds at positions that are rarely targeted by other biooxidation 
systems known so far (see section 4.1). Thus, CYP264B1 is a promising candidate for 
novel biotechnological processes and applications, especially exploiting new 
sesquiterpene derivatives.  
Due to the high costs of pyridine nucleotide cofactors as well as the laborious protein 
purification steps, it is not economic to use isolated enzymes for the production of these 
compounds in a large scale. In contrast, using a recombinant whole-cell biocatalyst is 
economically advantageous and very convenient, because not only the cofactor is 
provided by the host cell (it is regenerated simultaneously in the cellular metabolism), 
but also the P450 systems are stabilized (Maurer et al. 2005). The biggest challenge in 
the field of biocatalyst are such cofactor-dependent redox reactions (Zhao and van der 
Donk 2003; Urlacher et al. 2004; Hannemann 2006). To overcome this problem, several 
methods have been developed for the regeneration of cofactors using enzymes and 
whole cell based systems (Wandrey 2004; Wichmann and Vasic-Racki 2005). A 
recombinant E. coli whole-cell catalyst containing CYP106A2 and its redox partners 
was successfully applied for the conversion of 11-deoxycorticosterone (DOC) to 15-
hydroxy-DOC (Hannemann et al. 2006). Additionally, an efficient E. coli whole-cell 
catalyst by integrating heterologous cofactor regeneration, combining glucose facilitator 
and dehydrogenase, for the conversion of P450(BM-3)’s substrate was also reported 
(Schewe et al. 2008). Likewise, a new Bacillus megaterium whole-cell catalyst for the 
hydroxylation of the pentacyclic triterpene 11-keto--boswellic acid has been 
successfully used (Bleif et al. 2011).  
Since E. coli is a well studied bacterium and does not contain a P450 gene in its 
genome, the organism is a suitable host for the characterization and application of 
P450s (Agematu et al. 2006). We therefore created an E. coli whole cell system in 
which CYP264B1 was co-expressed with its heterologous redox partners AdR and Adx 
for the production of sesquiterpene derivatives. This system was tested for β-ionone 
conversion using E. coli C43(DE3) as host cell. Substrate was added into the culture 
medium 24 hours after induction. Then, after 24 or 48 hours, the compounds in the 
culture medium were extracted and monitored using a HPLC separation system. The 
result demonstrated that the specific product of CYP264B1 (3-hydroxy-β-ionone) was 
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formed. However, besides this product, another product peak at later retention time was 
also found. In the control strain of E. coli carrying pET17b, pETMR5 or pETC4, only 
this side product was observed (data not shown). This result indicated that 3-hydroxy-β-
ionone is the sole product of CYP264B1 and that the side product is produced by other 
enzymes of this strain. As discussed above (see section 4.1), β-ionone could be 
transformed by various bio-systems into different derivatives, but not into 3-hydroxy-β-
ionone. Therefore, this is the first system for the conversion of β-ionone into 3-hydroxy-
β-ionone. The product yield of 3-hydroxy-β-ionone was estimated to be 48 mg/L 
culture per day under non optimized laboratory conditions. In addition, the optimal time 
after induction for taking samples is around 24 h. 
Taken together, an E. coli whole-cell system for the transformation of sesquiterpenes 
was constructed. CYP264B1 and its heterologous redox partners Adx and AdR were 
expressed functionally in C43(DE3). This system was successfully applied for the 
conversion of β-ionone and therefore provides an opportunity for the conversion of 
other substrates of CYP264B1, including valencene, clovene and humulene.   
4.3. Characterization of GeoA and identification of the TPSgc
Terpenoids comprise a highly diverse class of natural products (Martin 2003) They play 
multi-functional roles in plants, human health and commerce (see introduction). The 
primary enzymes responsible for the synthesis of these compounds are terpene cyclases. 
Genome mining of the myxobacterium So ce56 - a very promising source for the 
discovery of novel classes of secondary metabolites revealed three putative terpene 
cyclase genes (locus_tag sce1440, sce6369 and sce8552). Among them, the terpene 
cyclase GeoA (locus_tag sce8552) is located downstream of CYP264B1. The distance 
of 63 base pairs between them implies that they are likely arranged in an operon and 
together involved in the biosynthesis of terpenoids in So ce56. Due to the economic and 
biological significance of the terpenoids, we were interested in the characterization of 
the terpene cyclase GeoA, especially in the role of the TPSgc encoding enzymes 
CYP264B1-GeoA in the terpenoid biosynthesis of this myxobacterium.  
The gene encoding for GeoA was cloned into vector pET17b and expressed in 
BL21(DE3). Similar to CYP264B1, the expression of GeoA in this strain required the 
support of the molecular chaperones GroEL and GroES. The explanation for this has 
been discussed for CYP264B1 (see section 4.1). To indentify the substrate(s) of this 
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terpene cyclase, three common substrates of terpene cyclases (GPP, FPP, GGPP) were 
tested in the in vitro conversion. GC-MS analysis of the conversion of FPP and GGPP 
revealed a product peak at 20 and 30 min, respectively. This result indicated that FPP 
and GGPP were substrates of GeoA. In a similar manner to many terpene cyclases 
analyzed so far, GeoA required Mg2+ as a catalyst. No activity was detected when this 
divalent metal ion was absent. The important aspartate-rich region of all terpene 
synthase enzymes, the DDxxD, has been proved to be responsible for the binding of 
divalent metal ions that later react with the diphosphate moiety of the substrate 
(Degenhardt et al. 2009). This region was found to start at Asp-91 of GeoA. The 
conserved triad NDXXSXXXE motif was also found in this enzyme, beginning at Asn-
231. This motif is believed to play a role as an additional metal cofactor binding motif 
located on the opposite site of the active site entry (Rynkiewicz et al. 2001). The 
deduced amino acid sequence of this terpene cyclase exhibits the highest identity to a 
monoterpene cyclase for the biosynthesis of the off-flavor terpenoid alcohol-2-
methylisoborneol (2-MIB) of Roseiflexus castenholzii DSM 13941. Nevertheless, it is 
able to convert both FPP and GGPP into a sesquiterpene and diterpene, respectively, but 
not GPP into monoterpene. Thus, it can be stated that this enzyme belongs to both, the 
sesquiterpene and diterpene cyclase group. Similar characteristics were observed for 
pentalenene synthase (Cyc2) of Streptomyces strains Kitasatospora griseola - a 
terpentecin producer (Dairi 2005). GCMS analysis showed that GeoA converted FPP 
into a product which has 89% similarity with the sesquiterpene valencene. For the 
GGPP conversion, a product which has 80% similarity with the diterpene neocembrene 
A was found. According to the NIST database 2.0, the values above 80% are good 
matches. Therefore, valencene and neocembrene A are potential products of GeoA.  
In the genome of So ce56, CYP264B1-coding gene is located upstream from geoA. For 
that reason, this P450 was believed to be responsible for modifying further the product 
of the terpene cyclase GeoA by creating specific functional groups on these compounds. 
Because CYP264B1 has been identified as a novel hydroxylase, it is suspected to 
hydroxylate the product of terpene cyclase GeoA. A terpenoid synthesis route through 
the TPSgc encoding enzymes CYP264B1-GeoA was thus postulated (see section 3.3.1; 
Figure 3.26). The first step is cyclization of FPP or GGPP by GeoA to sesquiterpene X 
or diterpene Y to establish the basic skeleton. The further step is oxygenation of these 
terpenes by CYP264B1 to the sesquiterpenoid X-OH or the diterpenoid Y-OH. To 
confirm this postulation, the CYP264B1 reconstitution system was added to the 
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incubation of GeoA with either FPP or GGPP. Under this reaction condition, the 
formation of the products X-OH and Y-OH was observed. On the other hand, these 
products were not formed by a reaction in which CYP264B1 was inactivated. This 
result confirmed that the sesquiterpene X and the diterpene Y were converted into X-
OH and Y-OH by CYP264B1 and that they are the real products converted from FPP 
and GGDP by GeoA. As mentioned above, valencene is a possible sesquiterpene 
product of GeoA. However, CYP264B1 converts valencene into 5 products whereas it 
converts the sesquiterpene intermediate of GeoA into only one product (see section 
3.3.2). Thus, the sesquiterpene X can not be valencene. This result indicates that the 
metabolites of the TPSgc encoding enzymes are new compounds which are not included 
in the NIST database yet. 
In order to see whether other CYPs of So ce56 are able to convert the products of GeoA 
or not, 5 enzymes (CYP264A1, CYP109C2, CYP109C1, CYP109D1, CYP260A1) 
were tested. These enzymes (kindly provided by Dr. Khatri) can be supported by the 
heterologous redox partners AdR and Adx. Among them, CYP109D1 was able to 
hydroxylate α- and β-ionone (Khatri et al. 2010), CYP206A1 was able to hydroxylate 
nootkatone (Ewen 2009). Nootkatone and α-/β-ionone are also substrates of 
CYP264B1. Interestingly, under similar condition applied for CYP264B1, none of the 
selected cytochromes P450 was able to convert the intermediates sesquiterpene X and 
diterpene Y of the terpene cyclase into further products. This result demonstrates that 
the sesquitepene X-OH and the diterpene Y-OH are only formed by the cytochrome 
P450 CYP264B1 of the Soce 56. Futhermore, it indicates that the TPSgc encoding 
enzymes could be involved in the biosynthesis of both sesquitepenoids and diterpenoids 
in the So ce56. However, according to our observation, the role of this cluster was 
suspected to be responsible for the synthesis of sesquiterpenes rather than diterpenes in 
the myxobacterium So ce56 because of three following reasons. Firstly, CYP264B1 in 
this cluster is capable of hydroxylate diverse sesquiterpene substrates (see section 
3.1.6). Secondly, under the same conditions using the system with CYP264B1 and 
GeoA, the sesquiterpene product from FPP was observed much more clearly than the 
diterpene product from GGPP. Thirdly, the genomic organization of the gene cluster 
encoding for CYP264B1 and GeoA is similar to the sesquiterpene biosynthesis gene 
cluster of Streptomyces avermitilis (Quaderer et al. 2006) and the sesquiterpene 
biosynthesis gene cluster of Streptomyces coelicolor A3 (Zhao et al. 2008). For these 
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reasons, more attention should be address to the sesquiterpene synthesis through this 
gene cluster.  
Taken together, the terpene cyclase GeoA was successfully expressed, purified and 
characterized. The substrates of this enzyme were found and the products were detected 
by GC-MS. The sesquiterpene product and diterpene product are similar to valencene 
and neocembrene A, respectively. In addition, the functional relation between 
CYP264B1 and GeoA has been shown and their products were detected. The TPSgc
was thought to be involed in the sesquiterpene biosynthesis in the myxobacterium So 
ce56.  
4.4. Investigation of the terpene production in engineered E. coli
In present work, FPP and GGPP were identified as substrates of the terpene cyclase 
GeoA. Sesquiterpene and diterpene products were observed but they were proven to be 
novel metabolites which are not included in the NIST database yet (see section 3.3.2). 
Therefore, the identification of products (sesquiterpenes X and X-OH, diterpenes Y and 
Y-OH) of TPSgc encoding enzymes by NMR analyses is needed. To get sufficient 
amounts of products for NMR, in vitro conversion is not a desirable solution due to the 
very expensive precusor FPP, the expensive cofactor NADPH as well as purification of 
four proteins (GeoA, CYP264B1, Adx and AdR). An alternative approach is using 
metabolically engineered microorganisms as a host for heterologous production of 
isoprenoid compounds. For such purpose, E. coli is an attractive candidate because of 
extensive molecular genetic resources and the ease of genetic manipulation. This 
microorganism has been used as a host for the heterologous production of terpenoids 
(Martin et al. 2003, Harada 2009; Chang et al. 2006) and carotenoids (Albrecht et al. 
1999; Alper et al. 2005; Farmer and Liao 2000; Vadali et al. 2005). It is known that E. 
coli does not synthesize isoprenoids such as monoterpenes, diterpenes, sesquiterpenes, 
but they synthesize IPP and DMAPP precursors through a non-mevalonate (MEP) 
pathway for the prenylation of tRNAs and the synthesis of FPP, which is used for 
quinone and cell wall biosynthesis (Connolly and Winkler 1989; Apfel et al. 1999; 
Martin 2003; Harada et al. 2009). However, the level of FPP is rather low and by no 
means sufficient for biotechnological applications. Therefore, in order to turn E. coli
into a suitable host for the production of terpenoids, a series of biosynthesis genes 
encoding enzymes catalyzing several steps from FPP to the desired isoprenoids have 
been introduced into E. coli which enable it to synthesize these compounds from 
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intracellular FPP (Yokoyama et al. 1998; Harada et al. 2009). Many studies on 
pathway-engineering have been performed for increasing intracellular pools of IPP and 
DMAPP (Wang et al. 1999; Matthews and Wurtzel 2000; Kim and Keasling 2001; 
Reiling et al. 2004). For example, FPP amounts increased significantly when the 
intrinsic 1-deoxy-D-xylulose-5-phosphate synthase or 1-deoxy-D-xylulose 5-phosphate 
reductoisomerase gene in the MEP pathway was over-expressed in E. coli, resulting in 
an increase of the desired terpenoid yield (Albrecht et al. 1999). Similarly, the FPP 
content was enhanced several times when the IPP isomerase gene derived from green 
alga Haematococcus pluvialis or yeast S. cerevisiae was expressed in E. coli (Yuan et 
al. 2006). Although engineering the native MEP pathway has received a lot of attention, 
introducing the heterologous mevalonate pathway into E. coli seems to be more 
attractive, since it has been demonstrated to be a superior biosynthetic route for 
delivering high-level precursors to terpene synthases for large-scale production of 
isoprenoids (Kakinuma et al. 2001; Martin et al. 2003; Vadali et al. 2005; Yoon et al. 
2006; Harada et al. 2009). But also introducing just a foreign partial (bottom) 
mevalonate pathway into E. coli and supplementing the culture medium with 
mevalonate significantly increased lycopene production in E. coli (Yoon et al. 2007). 
Based on these observations, we introduced enzymes of the mevalonate pathway in E. 
coli and coexpressed them with GeoA and CYP264B1 for sesquiterpene production. 
The two mevalonate vectors (pAC-Mev and pAC-Mv) used in this work have been 
reported in context with efficient synthesis of α-humulene (Harada et al. 2009) and β-
eudesmol (Yu et al. 2008) in E. coli.  
Because poor expression of heterologous GeoA and CYP264B1 in E. coli would limit 
the terpene production, optimizing the expression conditions was a primary task. At the 
beginning of this work, BL21(DE3) was used for the expression of CYP264B1 and 
terpene cyclase GeoA. This strain is commonly used as a host for the synthesis of a 
foreign proteins using pET vectors. However, we found that both, CYP264B1 and 
GeoA, can only be expressed in this strain when they are co-expressed with the 
molecular chaperones GroEL and GroES (see section 3.1.1 and 3.2.3). Therefore, 
C43(DE3) - a mutant strain of E. coli BL21(DE3), was applied. This strain is often used 
to overcome the toxicity when recombinant proteins are over-expressed using the 
bacteriophage T7 RNA polymerase expression system (Dumon-Seignovert et al. 2004). 
We found that CYP264B1 and GeoA could be expressed in C43(DE3) without co-
expression of chaperones. Furthermore, using this strain for the whole cell conversion 
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of β-ionone by CYP264B1, the product 3-hydroxy-β-ionone was obtained with high 
yield (see section 3.1.9), confirming that CYP264B1 and its redox partners (Adx and 
AdR) were functionally expressed. For this reason, we used C43(DE3) for the 
production of terpene compounds.  
We first investigated the efficiency of the production of the terpene cyclase products in 
E. coli C43(DE3). Cells carrying pAC-Mev or pAC-Mv together with pETG were 
cultured in TB medium supplemented with mevalonate. Since sesquiterpenes are 
volatile, we overlaid the culture with decane, an organic solvent with high 
hydrophobicity and low volatility to capture volatile compounds. This solvent has to be 
proved not to affect cell growth (Wang et al. 2010). GC-MS analysis of the decane 
phase 48h after induction showed that the sesquiterpene X was formed. The mass 
spectrum of the sesquiterpene product obtained in the in vivo conversion matched 
perfectly with the one of the product observed in the in vitro conversion of FPP by the 
terpene cyclase GeoA. Interestingly, when mevalonate (0.5 mg/ml) was supplied to the 
medium, sesquiterpene production was improved about 2.5 fold  (see section 3.4.2). 
This result demonstrates that GeoA and enzymes of the mevalonate pathway are active 
in this strain. Using valencene as external standard for GCMS, the highest sesquiterpene 
yield was estimated to be 0.5 mg/50ml culture medium. Furthermore, the product yield 
in the strain carrying pAC-Mev was higher than in the strain carrying pAC-Mv (about 
1.2 times). In the control reaction (i.e. E. coli carrying just pAC-Mev or pAC-Mv), 
sesquiterpene X was not detected, confirming that E. coli itself did not produce this 
compound from the isoprenoid precursor. However, the yield of sesquiterpene X (≈ 10 
mg/l) was much lower than the yield of α-humulene (≈ 1 g/l culture) achieved by 
Harada et al (Harada et al. 2009) using the same vector pAC-Mev to boost isoprenoid 
synthesis. According to our observation, cell growth was considerably inhibited by 
decane, which might have caused the comparatively low yield. Although the conversion 
time was prolonged to 48 hours after induction, the optical density of the culture was 
very low (OD600 < 1.5). Therefore, we believe that the sesquiterpene X production can 
be further improved by using other systems instead of decane to capture the volatile 
products. 
In order to investigate the production of products of the TPSgc encoding enzymes in E. 
coli, we constructed the tetracistronic vector pETC4AAG containing genes coding for 
CYP264B1, Adx, AdR and GeoA. Co-expression of pETC4AAG and pAC-Mev in E. 
coli C43(DE3) was carried out in TB medium supplemented with mevalonate as 
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described in section 3.4.3. However, TLC analysis of the ethyl acetate extract from the 
culture revealed no product formation. Since CYP264B1, Adx and AdR was also shown 
to be expressed functionally in this strain (through the whole cell conversion of β-
ionone, section 3.1.9), possible reason for this result is the loss (due to volatility) of the 
hydrophobic sesquiterpene X from the cells. A strategy to overcome this shortcoming 
comes from the question: how to retain the volatile compound in the culture but do not 
disturb cell growth? For this purpose, cyclodextrins (CDs) are atractive candidates since 
they are well known as an enhancer of the permeation of poorly soluble compounds 
through biological membranes (Másson et al. 1999). They are used not only in drug 
delivery but also in bioconversion due to their biocompatibility with microbes (Singh et 
al. 2002). For example, in the precence of cyclodextrin, microbial transformation of 
cholesterol to androst-4-ene-3,17-dione increased up to 90% (Bar 1989). The 
explanation for the highly interesting application of cyclodextrins comes from their 
structural feature. CDs are circular oligosaccharides composed of (14)-linked -D-
glucosyl units with a shape as truncated cones (Szejtli 1998; Larsen 2002). The external 
surface of CDs is sufficiently hydrophilic to render them (or their complexes) soluble in 
water. In contrast, their interior is considerably less hydrophilic than the aqueous 
environment, thus it is able to hold appropriately sized non-polar moieties of other 
hydrophobic molecules within the cavity, without the formation or disturbance of 
covalent bonds (Munoz-Botella et al. 1995). The binding between the host CD and the 
guest molecule is rather in a dynamic equilibrium than being fixed or permanent (Jiang 
et al. 2010). Obviouly, substrate must be taken up by the microbe before being 
biotransformed (Goswami et al. 1983). One hypothesis is that CDs extract and form 
inclusion complexes with lipids and other hydrophobic moieties from the cell 
membrane, making it more permeable, which facilitates uptake of substrate into the E. 
coli cells (Aachmann and Aune 2009). In short, we supposed that the sesquiterpene X 
would be more accessible to the biocatalyst of CYP264B1 when using CD as a strategy 
for overcoming the volatile loss. Among different type of CDs, hydroxypropyl-β-
cyclodextrin seems to be the most efficient for enhancing biotransformation (Singer et 
al. 1991; Mahato and Garai 1997). Therefore we used this compoud for our experiment. 
Interestingly, after using this strategy, analysis of culture extracts by TLC, revealed a 
product which has a retention time identical to the one of the product of FPP in vitro
conversion by CYP264B1 together with GeoA. As expected, this product was not 
present in the control cultures (i.e. the same E. coli strain carrying pAC-MvC4) and 
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therefore thought to be the desired product. This result suggested that the production of 
sesquiterpene X-OH could be achieved by this system.  
After having discussed about the product formation from FPP by in vivo conversion in 
detail, we want to draw attention to the diterpene product from GGPP conversion. 
Interestingly, in the in vivo conversion system, neither diterpene Y (80 % similarity to 
neocembrene A) nor the derivative Y-OH were detected. However, it is known that E. 
coli does not naturally produce appreciable quantities of GGPP, the precursor for 
diterpene biosynthesis (Reiling et al. 2004). Assuming this is the reason for the failed 
attempt to produce the diterpene Y and its hydroxylated product in E. coli, the obvious 
solution would be to introduce and over-express a GGPP synthase gene in E. coli to 
increase the intracellular GGPP pool. A suitable GGPP synthase gene could be cloned 
from the genomic DNA of the myxobacterium So ce56. Among three candidates from 
So ce56 (locus_tag sce1722, sce3009 and sce4204), the most attention should be paid 
for the one of locus_tag sce1722 since its product is probable geranylgeranyl 
pyrophosphate synthase (NCBI). Another interesting suggestion comes from Ohnuma 
(Ohnuma et al. 1996): they suggested that GGPP synthase could be produced by 
mutating native FPP synthase IspA from E. coli (Tyr80 of IspA was mutated to an Asp 
residue) to avoid the vagaries of foreign protein production in E. coli (codon usage and 
quaternary or tertiary protein structure). This might certainly be important regarding So 
ce56’s high GC content. 
Accordingly, our current results suggests that amounts of sesquiterpene X and diterpene 
Y sufficient for NMR analysis can be obtained by using E. coli C43(DE3) as host and 
introducing the genes encoding the enzymes needed for the production of the respective 
isoprenoid precursors. In general, the product yield could be improved by optimizing 
culture conditions. For example, the carbon source can be an important factor effecting 
terpenoid yield. Indeed, both terpenoid production and cell growth can be significantly 
enhanced by proportionally increasing the available amounts of mevalonate and 
glycerol (Alper et al. 2005; Yoon et al. 2007). Glycerol was reported to increase 
carotenoid production, whereas glucose was found to decrease it (Lee et al. 2004; Tao et 
al. 2005). Furthermore, acetoacetate - a cheaper compound could substitute D-
mevalonate, using E. coli cells expressing acetoacetate-CoA ligase genes as well as 
mevalonate pathway genes (Harada et al. 2009). In addition, protein expression levels 
could likely be improved by substitution of the expression vector or host strain, or the 
use of codon-optimized genes (Harada et al. 2009; Martin 2003) using the E. coli codon 
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preferences. Higher yields can also be achieved by optimization of the culture 
conditions in a fermentor, where culture parameters like pH, dissolved oxygen, and 
substrate concentration can be controlled. 
In conclusion, terpene production in E. coli C43(DE3) using the mevalonate gene 
cluster of pAC-Mev and pAC-Mv were investigated. Although the products have not 
been identified, the result suggests the possibility to produce sufficient product amounts 
for NMR analysis, to clarify the role of the TPSgc in the myxobacterium So ce56.  
4.5. Outlook 
CYP264B1 is a potent sesquiterpene hydroxylase with the ability of performing the 
regioselective hydroxylation at unfavorable sites like C-13 of nootkatone and C-3 of β-
ionone. Thus, CYP264B1 is an attractive candidate for exploitation of norisoprenoids 
and sesquiterpene biotransformation. Among the identified subtrates, besides 
nootkatone and ionones, valencene and humulene also have interesting potential for 
further studies. Indeed, valencene is a precursor of nootkatone, the most important and 
expensive aromatic compound of grapefruit (Fraatz et al. 2009). Also, humulene is a 
precusor for the synthesis of zerumbone, a compound possessing anti-inflammatory and 
anti-HIV effects as well as anti-proliferative activities in a wide variety of cancer cell 
lines (Yu et el. 2011). To explore this intriguing P450, studies on protein crystallization 
and homology modeling for detailed knowledge about the structure of CYP264B1 
should be performed. In addition, with the aid of molecular biology techniques, such as 
directed evolution or site-directed mutagenesis to improve enzyme activity, substrate 
range or product formation, would provide a great potential for the exploitation of this 
enzyme, especially towards sesquiterpene compounds.
The E. coli whole cell system which was succesful applied for β-ionone conversion in 
this study could be applied for other substrates of CYP264B1. Especially, to overcome 
the loss of volatile substrates during biotransformation, using cyclodextrin might be a 
significant suggestion. 
The identification of the substrates of the terpene cyclase GeoA and the demonstration 
that the metabolites of the TPSgc encoding enzymes are novel compounds, which are 
not included in the NIST database yet, are important results for the continuing work. In 
comparison to CYP264B1, GeoA is less stable after purification because it is easier 
precipitated during storage. Therefore, in order to characterize this enzyme kinetically, 
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optimal pH, temperature conditions as well as additives (e.g. 2-mercaptoethanol, and 
Tween 80) which might help to enhance the activity of terpene cyclase, should be 
investigated.  
Although the question about the function of the TPSgc in the myxobaterium sorangium 
cellulosum So ce56 has not yet been fully answered, the investigation of the terpene 
production in mevalonate-engineered E. coli as well as a solution for overcoming the 
bottleneck during terpene biotransformation by using cyclodextrins, has pointed out that 
it is possible to get sufficient amounts of product for NMR analysis if laboratory 
conditions are optimized, and therefore the role of the TPSgc in the secondary metabolic 
pathways of So ce56 is going to be clarified.  
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5. SUMMARY 
In the work presented here, CYP264B1 and the terpene cyclase GeoA of Sorangium 
cellulosum So ce56 have been characterized.  
CYP264B1 is able to convert norisoprenoids (α-ionone and β-ionone) and diverse 
sesquiterpene compounds, including nootkatone. Three products, 3-hydroxy-α-ionone, 
3-hydroxy-β-ionone and 13-hydroxy-nootkatone were characterized using HPLC and 
1H and 13C NMR. CYP264B1 is the first enzyme reported to be capable to hydroxylate 
regioselectively both norisoprenoids at the position C-3 as well as nootkatone at the 
position C-13. The kinetics (Km and Vmax) of the product formation were analyzed by 
HPLC. The results of docking α-/β-ionone and nootkatone into a homology model of 
CYP264B1 revealed the structural basis of these selective hydroxylations. In addition, 
an E. coli whole cell system containing CYP264B1 and its redox partners was created 
for the biotransformation of CYP264B1 substrates. This system was applied 
successfully for β-ionone conversion. 
FPP and GGPP were found to be substrates for GeoA. The sesquiterpene and diterpene 
products of GeoA are similar to valencene (89%) and  neocembrene A (80%), 
respectively. However, these products are most likely new compounds. In order to 
characterize them by NMR, a whole cell system based on mevalonate pathway-
engineered E. coli was created to faciliate the production of sufficient amounts. The 
terpene production using this system was investigated, showing that it is possible to 
obtain the amounts required for NMR analysis if laboratory conditions are optimized. 
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ZUSAMMENFASSUNG 
In der vorliegenden Arbeit wurden CYP264B1 und die Terpencyclase GeoA aus So 
ce56  charakterisiert. 
CYP264B1 ist in der Lage, Norisoprenoide (α-Ionon und β-Ionon) und diverse 
Sesquiterpene, inklusive Nootkaton, umzusetzen. Drei Produkte (3-Hydroxy-α-Ionon, 
3-Hydroxy-β-Ionone und 13-Hydroxy-Nootkaton) wurden mittels HPLC und 1H und 
13C NMR charakterisiert. Damit ist CYP264B1 das erste Enzym, das die Fähigkeit 
besitzt, regioselektiv Norisoprenoide an Position C-3, sowie Nootkaton an Position C-
13 zu hydroxylieren. Die Kinetik der Produktbildung (Vmax und Km) wurde mittels 
HPLC analysiert. Durch das Docking von α/β-Ionon und Nootkaton in das 
Homologiemodell von CYP264B1 konnte die strukturelle Grundlage dieser selektiven 
Hydroxylierungen aufgeklärt werden. Des Weiteren wurde  ein E. coli Ganzell-
Sumsatzsystem für die Umsetzung von CYP264B1 Substraten etabliert, das neben 
CYP264B1 auch seine Redox Partner enthält. Dieses System wurde erfolgreich für 
dieUmsetzung von β-Ionon eingesetzt. 
FPP und GGPP wurden als Substrate von GeoA identifiziert. Die jeweiligen 
Sesquiterpen- und Diterpen- Produkte wiesen Ähnlichkeit mit Valencen (89%), bzw.  
Neocembren (80%) auf. Jedoch handelt es sich bei den gebildeten Produkten 
höchstwahrscheinlich um neue Verbindungen. Um ausreichende Mengen dieser 
Verbindungen für eine NMR Analyse zur Verfügung zu stellen, wurde ein Ganzzell-
System aufgebaut, das auf E. coli Zellen die heterolog zusätzliche Proteine des 
Mevalonat Stoffwechselweges exprimieren, basiert.  Durch weitere Optimierung dieses 
Systems sollte es in  Zukunft möglich sein, die für eine NMR Analyse erforderlichen 
Produktmengen produzieren.
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7. APPENDIX 
7.1. Media 
7.1.1. Luria-Bertani (LB) Broth 
Bacto-Tryptone 10 g 
Yeast extract 5 g 
NaCl 10 g 
Add H2O  1000 ml 
7.1.2. Terrific Broth (TB) 
Typtone 12 g 
Yeast extract 24 g 
Glycerin 4 ml 
Add H2O 900 ml 
After autoclaving, add 100 ml of sterilized potassium phosphate buffer: 
K2HPO4 0.72 M 
KH2PO4 0.17 M 
7.1.3. SOC medium 
Tryptone 20 g
Yeast extract 5 g
NaCl 0.5 g
Add H2O 980 ml
After autoclaving, add 20 ml of sterilized 1M glucose
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7.2. Preparation of chemically competent cells 
7.2.1. Transfer buffer I (TFPI) 
1M CH3COOK 3 ml 
1M KCl 10 ml 
1M CaCl2 1 ml  
Glycerol  12 ml 
Filled up to 80 ml with distillated water, adjusted pH to 6.1 
Add 1M MnCl2 5 ml  
Filled up to 100 ml with distillated water, pH should be 5.8. 
7.2.2. Transfer buffer II (TFPII) 
0.2M MOPS 1 ml 
1M KCl 0.2 ml 
1M CaCl2 1.5 ml 
Glycerol  2.4 ml 
Filled up to 20 ml with distillated water, pH should be 6.5-7.0. 
Both of TFPI and TFPII was sterilized by filtration and stored in the refrigerator at 4°C 
before used 
7.3. Buffers and solutions for protein purification
7.3.1. Cell lysis buffer: 50 mM Sodium phosphate buffer, pH 8.0; 300 mM NaCl; 20% 
Glycerin; 0.1 mM PMSF (stock solution: 100 mM in isopropanol) 
7.3.2. Buffer for affinity chromatography: 
Equilibrium buffer : 50 mM Sodium phosphate buffer, pH 8.0 300 mM NaCl 20% 
Glycerin, 20 mM imidazole
Elution buffer: 50 mM Sodium phosphate buffer, pH 8.0, 300 mM NaCl, 20% 
Glycerin, 150 mM imidazole 
7.3.3. Buffer for size exclusion chromatography: Potassium phosphate buffer (10 
mM, pH 7.4) containing 20% glycerol. 
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7.4. Sodium dodecylsulphate (SDS) polyacrylamid gelelectrophoresis 
7.4.1. Gel components  
Stock solutions Separating gel (15%) Stacking gel (5%) 
4 x LT 3.75 ml - 
4 x UT - 2.5 ml 
10% APS 75 µl 50 µl 
dest.H2O ad 15 ml Ad 10 ml 
30% AA/Bis 7.5 ml 1.6 ml 
TEMED 10 µl 5 µl 
7.4.2. Buffer and solution  
• 4 x Buffer for separating gel (LT): 1.5 M Tris/Cl, pH=8.8; 0.4% SDS 
• 4 x Buffer for stacking gel (UT): 0.5 M Tris/Cl, pH= 6.8; 0.4% SDS 
• 2 x SDS loading buffer: 125 mM Tris/Cl, pH=6.8; 20% Glycerol; 4% SDS; 
10% -mercaptoethanol; 0.004% Bromphenol blue  
• Staining solution: 0.1% Coomassie Brilliant Blue G-250; 40% Methanol; 10% 
Acetic acid 
• Destaining solution: 25% Methanol; 10% Acetic acid 
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7.5. The DNA sequence of gene coding for CYP264B1  
ATGACTCGACTTAATCTGTTCGCCCCCGAGGTCCGAGAGAACCCGTACCCCTTCTACGCGGCGCTGCGCC 
GCGAGTCGCCCGTGTGTCAGGTGGACCCCAACGGGATGTGGGTGGTCACCCGGTATGATGACATCGTGGC 
GGCGTTCAAGAACACGCAGGTGTTCTCGTCCGCGGGGCTGCGCATGGCCACCGAGCCTCCTTACCTGCGG 
CGTCAAAATCCATTGTCCGGATCCATGATCCTCGCGGACCCGCCGCGGCACGGACAGCTGCGCAGCATCA 
GCAGCCGTGCGTTCACCGCCAACATGGTGAGCACGCTGGAGCACCACATGCGATCCATGGCCGTGCGGCT 
CACGGACGACCTGGTGCACCGTCGCGTCGTCGAGTTTATCTCCGAGTTCGCGAGCCGCGCGCAGGTCAGC 
GTCCTCGCCAAGTTGATCGGATTTGATCCAGGGCTAGAGGGGCACTTCAAGCGATGGGCGACTGACCTGG 
TCATCGTTGGCGTCATACCTCCGGAGGATCATGCGCGGATCGCCGAGGTGCGCAGGACCATCGATGAGAT 
GGAGCAGTACATGCTGGGCCTGCTGGCGAGCCGCCGGCGTCATTTGGAGAACGATCTGGTAAGTGAGCTG 
CTCCGATCTCGGAGGGACGACGATGGCATCACGGACCAGGACCTCGTGTCCCTCCTCTCGCTGCTCCTCG 
TGGCAGGGCTCGAAACGTCGACATCGCTGATGACCCATATGGTCTTGATCCTCGCCCAGCGGCCGATGTG 
GATGGATCGCCTACGTGCGGAGCCCGCGCTCATCCCGCATTTCATCGAGGAGGTGATGCGTTTCGAGGCG 
CCTGTGCATGCCACGATGCGACTGACCGTCACCGAGACGGAGCTCGGCGGTACGCGTCTGCCCGCTCACG 
CCGTGGTCGCGCTGCTCATCAGCTCGGGTCTGCGCGATGAGGCGAGGTTCCAGGAGCCGGACCGCTTCAA 
CCCAGAGCGCGGCGATCAGGCCAACCTGGCATTCGGCCATGGTGCCCACTTCTGCCTCGGGGTCTTCCTG 
GCCCGGGTGCAGGCCCGCATCGTGCTGGAGGAGCTCCTCCGTCGGTGCCACCGCATCGTGCTTCGTACCG 
ACCGTCTCGAGTGGCAAGCGGCTCTCAACACGCGCTCCCCGGTGGCGCTGCCCATCGAGGTGATCCCCGT 
CTCGACTACCGCCGCACGTGAGTCGCCGGTCGTCCAGGGCATCTGGTAG 
7.6. The protein sequence of CYP264B1 
MTRLNLFAPEVRENPYPFYAALRRESPVCQVDPNGMWVVTRYDDIVAAFKNTQVFSSAGLRMATEPPYLR 
RQNPLSGSMILADPPRHGQLRSISSRAFTANMVSTLEHHMRSMAVRLTDDLVHRRVVEFISEFASRAQVS 
VLAKLIGFDPGLEGHFKRWATDLVIVGVIPPEDHARIAEVRRTIDEMEQYMLGLLASRRRHLENDLVSEL 
LRSRRDDDGITDQDLVSLLSLLLVAGLETSTSLMTHMVLILAQRPMWMDRLRAEPALIPHFIEEVMRFEA 
PVHATMRLTVTETELGGTRLPAHAVVALLISSGLRDEARFQEPDRFNPERGDQANLAFGHGAHFCLGVFL 
ARVQARIVLEELLRRCHRIVLRTDRLEWQAALNTRSPVALPIEVIPVSTTAARESPVVQGIW 
7.7. The DNA sequence of gene coding for GeoA  
ATGTCATCTGATCGAACTAGCGTTGTCGTCAGCAAGCGCGACGCTGGTGGATTCGAATATCCGTTTGCTG 
CGTCGTGTCACCCCGGGAGAGAGGTCACGGAGCAAAGGACCCTGGCGTGGGTTCGCCGGTTGCGTCTGGT 
GCCAGACGGTCGGTCGCTTTCACGTCTCAAGGCGACGAACTTCTCCCACCTGGCGGCATGGCTCTTACCG 
TCCGCGAGCACGCAGACGCTCCAGCTGGCATCGGACTTCACGGCCGTGCTGTTCCTCCTGGATGATGCGT 
ACGACGAGGGGCAGCTCAGCACGGACCCGGAATCCGTCGAGTGGCTCAACGAGAAGTACCTGGGTGAGCT 
CTTCGGGTACACCGAAGCGGACATGAGCGACCCCCTGACGCGCGGGATGCTCGATGTACGTGAGCGCATC 
CGACGCAGCCATCCGCACTTCTTCCTGAATCGCTGGCTCTCGCACTTTCAGTACTACTACGAGGCCAACC 
TGTGGGAGGCGAATAACCGAAAGCAGATGAGGGTGCCGCATCTTGAAGAATATTTGATGATGCGGCGCTA 
CAGCGGCGCTGTCTATACCTACTGTGACCTGCTCGAGCTGCTGCTCGAACGGCCGCTGCCGCTCGAGGTC 
GTCCAGCACCCGTTGATTCAGACGGTTCGAGACATCTGTAATGACATCCTCTGCTGGACGAACGACTACT 
TCTCGCTCGGGAAGGAGCTGACCAACGGCGAGACGCACAACCTGATCGTCGTTCTCCGGAACGAATGCGT 
GAGCACGCTGGAAGAGGCGATCGACCGGCTCAAGGACATGCACGACCGCCGGGTCGCGGAGTACCAAGGC 
GTGAAGGAGAAGGTGCTCGCGCTCTGGGCGGACGACGAGATCCGCCTCTACCTGGACGCGGTCGAGGCCA 
TGATCGCCGGGAATCAGCGCTGGGCGCTCGAGGCCGGTCGCTATTCTGGACTAGAAAGTTTGATCGTGCG 
CGCTGGATGA 
7.8. The protein sequence of GeoA 
MSSDRTSVVVSKRDAGGFEYPFAASCHPGREVTEQRTLAWVRRLRLVPDGRSLSRLKATNFSHLAAWLLP 
SASTQTLQLASDFTAVLFLLDDAYDEGQLSTDPESVEWLNEKYLGELFGYTEADMSDPLTRGMLDVRERI 
RRSHPHFFLNRWLSHFQYYYEANLWEANNRKQMRVPHLEEYLMMRRYSGAVYTYCDLLELLLERPLPLEV 
VQHPLIQTVRDICNDILCWTNDYFSLGKELTNGETHNLIVVLRNECVSTLEEAIDRLKDMHDRRVAEYQG 
VKEKVLALWADDEIRLYLDAVEAMIAGNQRWALEAGRYSGLESLIVRAG 
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7.9. Vector maps 
7.9.1. pET17b 
7.9.2. pETC4 and pETG 
CYP264A1
T7 
Term
pETC4 
Amp
NdeI HindII
pBR322 ori 
GeoA 
T7 
Term
pETG 
Amp
NdeI HindII
pBR322 ori 
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7.9.3. pETMR5 
7.9.4. pETC4AA 
7.9.5. pETGAA 
Term
CYP264A1
Adr Adx 1-108
T7 
pETMRTr5
Amp
HindII EcoRI
pBR322 ori 
Term
CYP264B1
Adr Adx 1-108
T7 
pETC4AA 
Amp
EcoRIHindII
pBR322 ori 
NdeI
Term
GeoA 
Adr Adx 1-108
T7 
pETC4AA 
Amp
EcoRIHindII
pBR322 ori 
NdeI
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7.10. Structure of screening compounds 
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7.11. Type I spectra changes of CYP264B1 upon binding of some sesquiterpenes 
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